Search Results

Highlights: ✅ High heart risk:  T2D triples the chance of cardiovascular hospitalization. ✅  At-risk groups:  Certain ethnicities and women with T2D face higher risk. ✅  Prevention works:  Lifestyle, ABCs (A1C, BP, Cholesterol), and heart-protective meds help. ✅  Tools & stories:  Patient experiences and Canadian resources guide action Every 29 September, World Heart Day  spotlights the global fight against cardiovascular disease (CVD). For people living with type 2 diabetes (T2D), and the clinicians who care for them, this date is a timely reminder that protecting heart health isn’t optional; it’s essential. In Canada, about 1 in 10  people are living with diagnosed diabetes, and prevalence has been climbing for years. Canadians with diabetes are roughly three times more likely to be hospitalized  for cardiovascular conditions than those without diabetes, underscoring the tight link between blood sugar and the heart. Zooming out, the relationship is just as stark: across large datasets, about one-third  (32.2%) of people with T2D live with CVD, and CVD accounts for ~half of deaths in this population. This link is so profound that a person with T2D and no history of CVD has a cardiovascular risk equivalent  to someone who has already had a heart attack.   Who in Canada bears the greatest burden of cardiovascular disease? Risk isn’t distributed evenly. First Nations and Métis people, and people of African, East Asian, and South Asian backgrounds experience higher rates of T2D, which, in turn, amplifies lifetime cardiovascular risk. Women with diabetes also face a disproportionate rise in heart-disease risk compared with men, with distinct presentation and outcomes captured by Heart & Stroke . Add social determinants , income, access to care, food and housing security, commercial tobacco exposure, and the gradient steepens. Clinically, that means earlier conversations, earlier screening, and earlier prevention  in these groups. The Patient Perspective: A Human Element Beyond the data, it's crucial to remember the human experience. The "Know Diabetes by Heart" initiative shares inspiring stories  of individuals navigating this dual diagnosis. For example, a patient named Annette, motivated by changes in her vision and her father's sudden death from a heart attack, took her T2D control seriously. These narratives serve as a powerful reminder of the impact of patient education and shared decision-making in improving outcomes. Interestingly, women with a history of gestational diabetes (GDM) have an almost 10-fold higher risk  of developing T2D than those who have not experienced GDM. This significant risk highlights the importance of early intervention to prevent T2D after pregnancy. Christina Stuwe - Heart and Stroke Foundation of Canada "After my baby’s birth, I was told that I might develop diabetes or an issue with sugar when I was older. There was no mention of my heart – nothing ." Christina Stuwe - living with heart disease. Why T2D and CVD travel together: the short science story Under the hood, multiple overlapping pathways drive atherosclerosis and heart failure in T2D: Insulin resistance & hyperinsulinemia  don’t just raise glucose; they’re pro-atherogenic and push vascular smooth-muscle growth. Chronic hyperglycemia fuels oxidative stress and advanced glycation end-products (AGEs) , injuring endothelium and accelerating plaque. Diabetic dyslipidemia  (high TG, low HDL, small dense LDL) is especially atherogenic. Inflammation & thrombosis  add the final spark—chronic cytokine signaling, platelet activation, and hypercoagulability. From evidence to action: what to prioritize in clinic The 2025 ADA Standards of Care  and ESC guidance on CVD in diabetes  align on a cardio-renal protective strategy: Medication choices with CV benefit: in people with T2D and established CVD, or at high CV risk, use SGLT2 inhibitors and/or GLP-1 receptor agonists with proven outcome benefits, regardless of baseline A1C or metformin status. Treat the “ABCs” hard: A1C, Blood pressure, Cholesterol, with statins as default unless contraindicated; consider 10-year ASCVD risk and shared decision-making. Lifestyle is therapeutic: diet quality, physical activity, sleep, stress, and smoking cessation pull real levers on risk. One of the best illustrations remains the Steno-2 trial : an intensive, randomized control trial using multi-factorial programs (glucose, BP, lipids, renin-angiotensin blockade, aspirin, lifestyle). Those who received an intensive, all-around treatment plan, including lifestyle changes and medications, lived almost 8 years longer than those who got standard care (at 21 years follow up). They also went about 8 years longer without developing heart problems, and most diabetes-related complications were lower in the intensive treatment group. Steno-2 Trial summary of results What’s new in the science? Genetic/epigenetic risk stratification at diagnosis: In August 2025, a Lund University team reported a DNA-methylation–based tool derived from 752 newly diagnosed T2D patients followed for seven years. It showed excellent ability to rule out high CV risk (negative predictive value ~96%), with more modest performance identifying the highest-risk group—promising for personalizing treatment intensity alongside clinical variables. Read the paper in Cell Reports Medicine . Youth signals, adult consequences: A Diabetes Care study tracking 1,595 participants from age 17 to 24 found that persistent high fasting glucose was associated with a 46% increased risk of left ventricular hypertrophy (LVH) by young adulthood—even below some diagnostic thresholds for diabetes. Early prevention (nutrition, activity, weight optimization, sleep, stress) isn’t just about preventing diabetes later—it may protect the heart now. Read more in Diabetes Care  and the University of Bristol summary . Test your knowledge: a quick case quiz A 63-year-old man  with T2D, hypertension, and a smoking history reports several weeks of exertional chest tightness and mild dyspnea when mowing the lawn. No rest symptoms. How do you risk-stratify , which immediate tests  do you order, and how would medication choices  change post-diagnosis ? Canada-ready tools you can use tomorrow If you want a quick, Canadian-calibrated way to estimate 10-year CVD risk and guide conversations, try the PEER Simplified Cardiovascular Decision Aid  (English/French). It’s built for primary care workflows and easily supports shared decisions on statins, BP meds, and smoking cessation. Working with patients? Hand them: Take Diabetes to Heart (NIDDK) – printable fact sheet  on why A1C, BP, and LDL all matter for the heart. Monitoring My Health toolkit (HeartLife Foundation)  to track meds, symptoms, and tests between visits. Smoking cessation supports via Heart & Stroke: Smoking and tobacco  and Health Canada’s “Smoke Free Curious” hub . For clinicians in BC, Cardiac Services BC  maintains decision tools, medication pathways, and printable resources (e.g., HF algorithms ). Nationally, bookmark the Canadian Cardiovascular Society (CCS) Guidelines  and their free CCS Pocket Guides  for point-of-care reference. As you can see from the case study above, translating this understanding into clinical practice requires a holistic, multi-factorial approach. As highlighted in a case study from the American College of Cardiology, a patient with a history of T2D, hypertension, and a smoking history presented with exertional chest pain, ultimately revealing signifi cant coronary artery disease. This underscores the need for aggressive risk factor management. The confluence of T2D and CVD demands a comprehensive, integrated approach. By understanding the intricate pathophysiology and leveraging evidence-based clinical strategies, we can move from simply managing individual diseases to fundamentally altering the trajectory of our patients' health.

Key Highlights ✅ 80% of adults with diabetes report stigma; 20% report discrimination. ✅ India could see 134.3 million people living with diabetes by 2045, the highest globally. ✅ An India-based study found mild but socially significant stigma around diabetes. ✅ Cultural beliefs reinforce fatalism and shame, undermining self-care and mental health ✅ Global studies show stigma raises HbA1c, worsens complications, and reduces healthcare engagement. Type 2 diabetes (T2D) is a growing global health crisis, affecting over 422 million people  worldwide. India stands at the forefront of this epidemic, with projections estimating that 134.3 million people  could be living with diabetes by 2045. While much attention has been paid to the clinical and lifestyle aspects of the disease, less is understood about its social and cultural dimensions , especially the stigma that shadows many living with this chronic condition. A recent study published in the Indian Journal of Community Medicine  sheds light on this very issue. Conducted in the urban slums of Pune, India's 7th most populous city , the study explores how stigma related to T2D manifests in everyday life, with far-reaching consequences for mental health, social mobility, and healthcare access. Pune, India Understanding the Cultural Stigma in Urban India The Pune study used a cross-sectional, community-based survey of 100 non-diabetic residents to i nvestigate public perceptions of diabetes. Using a locally adapted Explanatory Model Interview Catalog (EMIC) , researchers uncovered significant insights: while diabetes awareness was high, so was a pervasive fatalism. More than half of the participants believed untreated diabetes to be fatal , which reinforced negative perceptions of the disease. The stigma index derived from survey responses was 7.22 out of 36, a score reflecting a mild but socially meaningful level of stigma . Despite being “mild,” this stigma was expressed through: Concealment of diagnosis , especially among married individuals, due to fear of social judgment. Difficulties in arranging marriages , particularly for unmarried individuals and those from non-Hindu or marginalized communities. Workplace discrimination , where diabetes was seen as a liability. WHO Stigma Campaign These findings highlight the intersection of health and culture, particularly how caste, religion, and marital status amplify the social challenges faced by those with diabetes. As the researchers noted, stigma was not only a product of misinformation but was deeply embedded in cultural norms around marriage, productivity, and self-reliance . The Emotional and Psychological Impact The social stigma of diabetes is more than an abstract cultural issue, it carries real emotional weight. The Centers for Disease Control and Prevention (CDC)  states that stigma can cause feelings of guilt and sham e that undermine diabetes management. Individuals living with diabetes often internalize societal judgments , leading to: Low self-esteem Depression and psychological distress Avoidance of medical care and reduced self-care behaviors In India, the stigma surrounding diabetes, especially for young women , is deeply connected to the issue of marriage . Many families are reluctant to accept a diabetic individual as a potential spouse, fearing the everyday management needs, risk of complications, and misconceptions about fertility or health, which leads to discrimination and social exclusion in the matrimonial context. This stigma often forces diabetics and their families to lower expectations , make compromises on caste or socioeconomic status, and sometimes conceal the condition entirely, contributing to feelings of depression, anger, and frustration for those affected. Despite these challenges, dedicated diabetic marriage bureaus and advocates  are working to shift mindsets, provide emotional support, and demonstrate that diabetes can be effectively managed with the right care, offering hope for social change and more inclusive attitudes in the future Even with legal protections in place, such as the Madras High Court ruling  affirming that diabetes should not disqualify someone from employment, stigma continues to manifest subtly, particularly in professional settings. A Global Perspective: Parallels in the Evidence The cultural stigma of diabetes isn't unique to India. A r eview of studies focusing on immigrants with diabetes, the majority of which were to the U.S. (71.9%), found that social exclusion stemming from diabetes diagnosis heightened diabetes distress , a condition that disrupts emotional well-being and leads to poorer self-care. Cultural beliefs around shame and personal failure were shown to directly impact glucose management, physical activity, and dietary adherence, ultimately raising HbA1c levels  and complication risk. This research used an integrative model that links cultural, psychological, behavioral, and biological factors, offering a more complete understanding of how stigma affects health. Similar themes have been observed among other immigrant communities , where language barriers, lack of social support, and limited health literacy  amplify the burden of managing diabetes. This is echoed by global research. An international panel of 51 experts from 18 countries conducted rapid reviews and a Delphi survey to build consensus on how to address this issue. They agreed on 25 evidence statements and 24 recommendations, highlighting that diabetes stigma is largely driven by blame, perceptions of burden, invisibility, and fear . Alarmingly, 80% of adults with diabetes report experiencing stigma, and 20% report discrimination in areas like healthcare, education, and employment. The panel unanimously declared that stigma is harmful, unethical , and must be actively challenged through collective leadership, culminating in a global pledge to end diabetes stigma and discrimination. Similarly, in a recent international review , diabetes stigma was noted as a significant social burden affecting people with both type 1 and type 2 diabetes. Stigma, experienced through negative judgments, stereotypes, or prejudice , can occur in healthcare, workplaces, schools, relationships, and media. The review outlines methods for measuring stigma and examines how it varies by age, diabetes type, and social factors. Reported prevalence is alarmingly high: up to 78% in adults with type 1 diabetes (T1D), 70% in adults with T2D, and 98% in youth with T1D. While data on youth with T2D is limited, one study found links between stigma and poorer psychosocial functioning, elevated HbA1c, and diabetic complications like retinopathy. Across populations, diabetes stigma is consistently associated with worse self-care, higher HbA1c levels, and increased rates of serious complications such as diabetic ketoacidosis and severe hypoglycemia. The review also underscores the need for further research, particularly among youth with T2D, to better understand how stigma drives these adverse outcomes. Diabetes stigma is a widespread and harmful issue that affects the majority of people with diabetes globally, contributing to poor psychosocial well-being, reduced self-care, higher HbA1c levels, and increased risk of complications, underscoring the urgent need for collective action and further research, especially among youth with T2D. Toward a Solution: Combating Diabetes Stigma Whether in Pune or Los Angeles, the impact of diabetes stigma is clear. Effective leadership from all sectors is required to actively confront and eliminate the stigma and discrimination associated with diabetes. To reduce its reach, multi-layered strategies must be adopted: 1. Educate the Public Let’s start by busting the myths. Diabetes is manageable. With early diagnosis, healthy lifestyle changes, and consistent care, people with diabetes can live full, healthy lives. Spreading this message is key. 2. Create Culturally Relevant Awareness Campaigns Messages that truly resonate come from within the community. Using familiar language, traditions, and trusted voices like local leaders can help challenge stigma and make conversations about diabetes more open and supportive. 3. Rethink How Healthcare Works Diabetes care should go beyond prescriptions. That means including mental health support and training healthcare professionals in cultural competence. When care is personalized and respectful of a patient’s background, it builds trust and leads to better outcomes. 4. Push for Policy and Advocacy Laws matter. Enforcing anti-discrimination policies and funding programs that support the emotional and social sides of diabetes can help protect patients at work, in schools, and in healthcare settings. 5. Strengthen Community and Family Support No one should feel alone in managing diabetes. Support from family, friends, and community groups makes a huge difference. When people feel understood and backed by others, they are more likely to take care of their health. Public campaigns like "Above the Bias" and many others calls for collective leadership across all sectors to tackle and eliminate the stigma and discrimination faced by those with diabetes. By challenging harmful stereotypes and promoting inclusivity, the campaign aims to foster a more supportive environment for people with diabetes, improving their access to care, mental well-being, and overall quality of life. With a focus on education, policy reform, and community engagement , this initiative seeks to create lasting change and ensure people with diabetes are treated with respect and empathy. The Pune study and other global findings make one thing clear: addressing the stigma surrounding T2D is not a secondary concern, it’s central to improving outcomes. Cultural stigma erodes the foundation of self-management, damages mental health, and widens healthcare disparities. Cultural values, beliefs, traditions, and family dynamics can serve as important guides when designing diabetes care strategies. Tailoring interventions around these cultural factors is likely to greatly enhance the effectiveness of diabetes management in the future. By acknowledging the socio-cultural dimensions of chronic disease , we take a critical step toward inclusive, patient-centered care. This means looking beyond blood glucose and HbA1c to see the human being behind the diagnosis, someone who deserves dignity, support, and freedom from judgment. T2D is not just a health condition. It’s a social experience, one that must be understood in its full cultural, psychological, and systemic complexity. By breaking the silence and addressing stigma head-on, we can empower millions to manage their diabetes with confidence, care, and community. Read more in our peer review publication focused on the importance of South Asian tailored interventions in diabetes management. Watch our vodcasts with on tackling diabetes stigma on our T2DNetwork YouTube channel Listen to the podcast version of this blog on your phone

Key Highlights ✅ Severe hypoglycemia can appear identical to a drug overdose ✅ Symptoms like seizures, confusion, or unresponsiveness require fast and accurate response ✅ Misdiagnosis can delay care, naloxone won’t help, but glucose or glucagon will ✅ Public awareness is essential, know the signs, act quickly, and reduce stigma ✅ International Overdose Awareness Day (Aug 31) is a chance to broaden understanding When first responders are called to someone who is unresponsive, seizing, or showing signs of altered consciousness, the immediate assumption is often drug overdose, especially in communities already navigating the opioid crisis. But there's another critical, and often overlooked, medical emergency that can present almost identically: severe hypoglycemia . This overlap in symptoms is especially relevant in the lead-up to International Overdose Awareness Day (August 31) , a global campaign led by the Penington Institute  to raise awareness of overdose, reduce stigma, and acknowledge the grief of those left behind. While the day focuses primarily on drug-related overdose, it’s also an opportunity to highlight other critical emergencies that can be mistaken for overdose, like hypoglycemia. But what exactly is hypoglycemia? For people living with Type 2 diabetes (T2D), especially those on insulin or certain oral medications, dangerously low blood sugar is a real and persistent threat. According to Diabetes Canada , diabetes-related hypoglycemia results in high cost to the person and the health system in Canada. And yet, this condition often flies under the radar, even among healthcare providers and emergency personnel. Hypoglycemia/Drug Overdose: Similar Symptoms, Different Causes Severe hypoglycemia can cause confusion, slurred speech, seizures, loss of consciousness, and in some cases, death, symptoms that closely mimic those of opioid or other drug overdoses. In fast-moving emergency situations, this similarity can lead to misdiagnosis or delayed treatment. Symptom Overdose Hypoglycemia Mental Status Confusion, disorientation, altered consciousness, unresponsiveness, stupor, coma Confusion, disorientation, difficulty concentrating, irritability, anxiety, unresponsiveness, coma Speech Slurred, incoherent, mumbled Slurred, incoherent, difficulty speaking Coordination/Movement Dizziness, unsteadiness, poor coordination, staggering gait Dizziness, unsteadiness, tremors, weakness, poor coordination Skin Appearance Pale, clammy, cool (opioids), flushed (stimulants), sweating Pale, clammy, sweating Heart Rate Can be slow (opioids) or fast (stimulants), irregular Rapid or pounding heart rate (palpitations) Breathing Slow, shallow, irregular, labored, depressed (especially opioids) Rapid, shallow (less common than mental changes) Other Notable Signs Pinpoint pupils (opioids), dilated pupils (stimulants), nausea, vomiting, seizures Intense hunger, headache, blurred or double vision, tingling around the mouth, seizures When blood glucose levels drop too low, the brain becomes starved of energy. This can result in acute neurological symptoms  that look indistinguishable from overdose, someone may appear unconscious, unresponsive, or combative. Why It Matters for People with Type 2 Diabetes While hypoglycemia is often associated with Type 1 diabetes; but people with Type 2 diabetes who use insulin or sulfonylureas are also at significant risk, especially: Older adults managing multiple medications Those with irregular meals or alcohol use People living alone or with cognitive impairment Individuals with reduced kidney function Not everyone experiences hypoglycemia differently. Hear how people with diabetes experience low blood sugar, what triggers their episodes, and how they manage it effectively. For these individuals , recognizing the early signs of hypoglycemia , shakiness, dizziness, sweating, or confusion, can be lifesaving. But once it progresses to seizures or unconsciousness, quick and correct identification is critical. Delays in treatment can be fatal. Misdiagnosis Can Have Serious Consequences Mistaking severe hypoglycemia for a drug overdose can have harmful consequences. People with diabetes may face stigma, judgment, or inappropriate treatment because their symptoms appear drug-related. For example, giving naloxone, a lifesaving antidote for opioid overdose, will do nothing in the case of hypoglycemia. What’s needed instead is immediate glucose administration or glucagon to restore blood sugar levels. This highlights the need for more informed and nuanced emergency responses that consider diabetes alongside substance use emergencies. What Needs to Change? As International Overdose Awareness Day approaches, it’s time to broaden our understanding of what “overdose” can look like, and who it affects. This includes expanding awareness to include conditions like diabetes-related hypoglycemia, which share similar clinical presentations but require entirely different interventions. Some key opportunities for action include: Training first responders and healthcare teams  to recognize hypoglycemia in addition to overdose Raising public awareness  about the symptoms of severe low blood sugar, especially for caregivers, teachers, and support workers Encouraging people with diabetes  to carry medical ID and have access to emergency glucose or glucagon Fostering collaboration  between harm reduction organizations and diabetes groups to share tools, training, and messaging Final Thoughts Severe hypoglycemia is a life-threatening complication of diabetes, and its resemblance to drug overdose symptoms can lead to dangerous delays in care. As we mark International Overdose Awareness Day on August 31, let’s also shine a light on the invisible emergencies faced by people living with Type 2 diabetes, and work together to ensure that all health crises are recognized and responded to with urgency, empathy, and accuracy. Learn more: International Overdose Awareness Day – August 31 Join us for more interesting insights Listen to the podcast version of this blog on your phone

Key Highlights ✅ Stigma is common, 92% of people with T1D and 68% with T2D report experiencing it ✅ Blame, judgment, and exclusion are major forms of diabetes stigma ✅ Stigma affects emotional well-being, self-worth, and quality of life ✅ People with T2D often face stereotypes that it's a “lifestyle disease” ✅ Healthcare providers can play a key role in reducing stigma through empathy and support Living with diabetes extends beyond just managing blood sugar; it involves navigating a world often fraught with misunderstanding, blame, and judgment. This often-invisible burden, known as diabetes stigma , significantly impacts the daily lives and well-being of those affected. A recent groundbreaking study, titled " A Square Peg in a Round Hole: Social Experiences of Living With Diabetes in Canada in 2024, " sheds critical light on this pervasive issue, revealing that 92% of Canadians with Type 1 diabetes and 68.2% of those with Type 2 diabetes report experiencing some form of stigma.  This comprehensive research highlights the urgent need to address the social and emotional realities faced by millions. The following CTV News video, "Breaking the stigma around diabetes," provides a personal perspective as it further explores this issue, featuring the "Above the Bias" campaign by Abbott and insights from individuals living with diabetes and healthcare professionals. A National Snapshot: How the Study Was Conducted In one of the most comprehensive examinations to date (published March 10, 2025), researchers from Dalhousie University , Diabetes Canada , Deakin University , and The Australian Centre for Behavioural Research in Diabetes  collaborated to shed light on the lived experiences of Canadians with Type 1 and Type 2 diabetes. Their study, A Square Peg in a Round Hole: Social Experiences of Living With Diabetes in Canada in 2024 ,  uncovers a troubling truth: stigma is a daily burden for most people with diabetes. Now let's take a closer look at what the study revealed, and why it matters more than ever. To truly understand what life with diabetes looks like across Canada, the researchers designed a nationwide survey that reached far and wide. Their goal? To capture the experiences of adults living with either Type 1 or Type 2 diabetes, in a way that reflected the diversity of people and places across the country. They began by working with Environics , a national market research company, which led the initial recruitment through its online panel. To broaden their reach, they also partnered with Diabetes Canada and dQ&A , a platform that amplifies the voices of people with Type 1 diabetes, to invite participants through email. To be eligible, individuals had to be 18 or older and have a confirmed diagnosis of Type 1 or Type 2 diabetes. To make sure all regions of the country were fairly represented, they used regional quotas during recruitment. In total, 1,799 adults  completed the survey: 786 people (43.7%)  were living with Type 1 diabetes (T1D) 1,013 people (56.3%)  were living with Type 2 diabetes (T2D) Participants completed a detailed survey that included several validated tools designed to explore a wide range of experiences, from emotional health and stigma to healthcare quality and daily life with diabetes. Some of the key assessments included: The Diabetes Stigma Assessment Scales  (DSAS-1 for T1D and DSAS-2 for T2D), which measured feelings of blame, judgment, and stigma, both from others and internalized. The WHO-5 Well-Being Index , a five-question scale that captured emotional well-being. The PAID-5 , which focused on emotional distress related to diabetes. The DAWN2 Impact of Diabetes Profile , which assessed how diabetes affects daily life. And the PACIC , which looked at how patient-centered people felt their healthcare had been. In addition to these scales, the survey gathered information on: Perceived discrimination Life satisfaction A1C levels Episodes of hypoglycemia Impact of excess weight Frequency of healthcare visits Sources of diabetes education and support As well as detailed demographic and clinical information , such as age, gender, ethnicity, education, income, treatment types, and duration of diabetes. The result? A powerful snapshot of what it means to live with diabetes in Canada today, one that highlights not just medical challenges, but social and emotional ones too. What They Found: The Heavy Toll of Stigma The results of the survey are hard to ignore: stigma is not just an occasional or isolated experience for people with diabetes in Canada, it’s widespread, and for many, it’s deeply damaging. Data specific to participants with T2D Across the country, 92% of adults with Type 1 diabetes (T1D)  and 68.2% of those with Type 2 diabetes (T2D)  reported experiencing some form of stigma related to their condition. Even more concerning, 34.2% of people with T1D  and 13.9% of people with T2D  said they had faced outright discrimination. These numbers paint a clear picture, most Canadians living with diabetes, especially those with T1D, are navigating a social world where they often feel judged, excluded, or misunderstood. Digging deeper into the data, the researchers used the DSAS-1 and DSAS-2 scales to explore the different ways stigma shows up in people’s lives. Blame and Judgment One of the most common, and harmful, forms of stigma was the assumption that people with diabetes were somehow responsible for their condition. About 72.5% of T1D respondents  said others believed they were less capable because of their diabetes, while 68.6%  felt judged for what they ate. For those with T2D, 40.7%  experienced stigma rooted in the belief that Type 2 diabetes is just a “lifestyle disease,” and 31.1%  reported being judged for their dietary choices. Being Treated Differently More than half, 54.1%, of people with T1D  said they had been rejected or excluded because of their diabetes. Many also described being treated as “less than” or facing discrimination in the workplace. Among those with T2D, 20%  felt they were perceived as "sick" or unable to perform regular duties, and around 10%  said they had experienced social exclusion. Identity and Self-Worth Stigma doesn’t just come from the outside, it often seeps in and affects how people view themselves. Among individuals with T1D, 44.2%  said they worried about injecting insulin in public, and 42.8%  felt embarrassed about experiencing low blood sugar. For people with T2D, the internal toll was also significant: 32.5%  reported self-blame, 27.4%  felt embarrassed about their condition, and 20.1%  said they felt guilty just for having diabetes. Clearly, stigma affects more than social interactions, it deeply impacts emotional and psychological well-being. How Stigma Affects Mental and Emotional Health The study also explored how stigma influences broader mental health and quality of life, and the results were troubling. Diabetes Distress : People who experienced stigma, whether from blame, judgment, or being treated differently, were more likely to report higher levels of diabetes-related emotional distress. Emotional Well-Being : Higher levels of stigma were linked to lower overall emotional well-being , especially among those who felt judged or blamed. Quality of Life : Stigma had a noticeable impact on day-to-day life, from work and relationships to social situations and self-care. Life Satisfaction : Among people with T2D, feeling stigmatized, particularly through internalized self-stigma or being treated differently, was associated with lower life satisfaction . Interestingly, among those with T1D, higher levels of blame and judgment were paradoxically linked with higher life satisfaction . Researchers suggest this might reflect resilience or strong coping strategies in this group. There was one somewhat hopeful finding: stigma didn’t seem to consistently affect people’s experiences with their healthcare teams. In fact, for people with T2D, being treated differently in society was positively associated  with feeling supported in clinical settings, suggesting that healthcare providers may be serving as a safe, empathetic space amid broader social challenges. Why This Matters - And What Needs to Change The findings from this study don’t just add to our understanding of diabetes stigma, they make a strong case for urgent action across healthcare, public health, policy, and research. For healthcare providers, empathy and awareness are absolutely essential. It’s not enough to focus solely on blood sugar levels or medication adherence, clinicians also need to recognize the emotional and social weight that stigma adds to the day-to-day management of diabetes. By incorporating routine screening for stigma during clinical visits, providers can help validate patients’ experiences and offer timely support, fostering trust and improving overall care. Public health campaigns also have a vital role to play. There’s a clear and urgent need for broader education efforts that challenge harmful myths, especially the persistent stereotype that Type 2 diabetes is simply the result of poor lifestyle choices. These campaigns should focus on promoting compassion, understanding, and accurate information about both Type 1 and Type 2 diabetes, helping to reduce blame and social judgment. When it comes to policy , this research offers strong support for the development of anti-discrimination protections. People living with diabetes deserve equitable treatment in all areas of life, including the workplace, schools, and public spaces. National-level policies that promote inclusivity and protect against discrimination must be a priority to ensure that people with chronic conditions like diabetes can fully participate in society without stigma or fear. Finally, the study highlights important directions for future research . Long-term studies are needed to understand how stigma changes over time and how it impacts physical and mental health outcomes. It's also crucial that future research efforts reach beyond online surveys and include the voices of communities that are often underrepresented, such as rural populations, Indigenous Peoples, and those living with lower incomes, to ensure a truly inclusive understanding of diabetes stigma in Canada. A Call to Action: Time for a Paradigm Shift This groundbreaking study offers a sobering reminder: living with diabetes in Canada isn’t just a medical journey; it’s a social one, too. The findings are clear: stigma is real, it is widespread, and it deeply affects emotional well-being, quality of life, and how individuals view themselves and their futures. Now more than ever, we need a paradigm shift : From judgment to empathy. From blame to understanding. From silence to advocacy. It’s time for all of us, healthcare providers, policymakers, educators, employers, and the public, to recognize the heavy, invisible burden that stigma adds to the lives of people with diabetes. The first step? Listening. Learning. And standing in solidarity with the 1 in 3 Canadians who live with diabetes every day, not just in managing their health, but in reclaiming their dignity. Because no one  should feel like a square peg in a round hole simply for living with diabetes. Read the article here: https://www.canadianjournalofdiabetes.com/article/S1499-2671(25)00052-8/fulltext Join our network to stay tuned for more interesting insights Listen to the podcast version of this blog on your phone

Blog highlights: ✅ Our website was co-designed with patients and clinicians to ensure the platform meets real-world needs. ✅ Features 375+ trusted, evidence-based resources in one centralized location. ✅ Built for accessibility and interactivity, including tools for tracking and peer support. ✅ Our new publication shares our step-by-step process as a blueprint for digital health innovation. Living with Type 2 Diabetes (T2D) is a constant challenge, and for too long, finding reliable, easy-to-understand information has added to that burden. Patients often spent hours sifting through countless websites, and even healthcare providers struggled to pinpoint the best resources for their clients. It was a fragmented mess, and frankly, it impacted people's health. That's why we were so thrilled to launch our centralized digital platform for T2D, the T2D Network , in British Columbia back in March 2025!  It's been live and making a difference, but we didn't want to keep our process a secret. We believe in collaborative innovation. So, we’ve now published (in press, open access full article expected in August) a detailed paper, " Designing a Centralized Digital Platform to Support Type 2 Diabetes: From Idea to Implementation ," to share exactly how we built this resource. Why This T2D Platform Matters (And How We Built It) When we set out, our vision was simple: one trusted place for everything T2D-related, for both patients and providers. The paper delves into the initial problems we faced, the fragmented information, the struggle for accessible content. Our aim was to create a tool that wasn't just available but truly actionable. And here’s the crucial part we've now shared in detail: how we ensured its effectiveness.  This platform wasn't just designed; it was co-created , ensuring every step was guided by real human needs: Patients at the Helm:  Nine individuals living with T2D (or at risk) from incredibly diverse backgrounds, were right there from day one. Their lived experiences shaped what the platform actually  needed to do to be helpful. Clinicians Lending Their Expertise:  Eleven dedicated healthcare professionals – educators, pharmacists, physicians, dietitians, nurses, and more – provided crucial clinical accuracy and ensured alignment with best practices. Constant Conversation & Iteration:  We baked feedback into every stage. Through interviews, focus groups, and usability tests, the platform evolved continuously. Seeing their suggestions implemented so quickly was incredibly motivating for our co-creators! What's Inside & Our Early Impact Drawing from extensive literature and all that invaluable user feedback, we crafted a platform packed with features designed to make life easier: A Goldmine of Resources:  Over 375 evidence-based resources  (and growing) gathered in one place, no more endless searching for credible info. Tools to Take Control:  Interactive features for tracking goals, monitoring progress, and getting personalized suggestions. Real Connection:  Spaces to connect with peers and find professional support. Built for Everyone:  Designed with accessibility in mind (WCAG 2.1 AA standards!), ensuring it works for people with diverse needs and tech skills. Our early months have already shown fantastic engagement: Over 1,300 website visits  and more than 750 unique individuals  have explored the platform. People are sticking around for over 4 minutes per session  on average – that's longer than what's typically seen for similar sites. And with a healthy 51% bounce rate , it means over half the visitors are exploring past their first page, showing real engagement. The Future is Shared: Our T2D Blueprint for Digital Health Innovation Our centralized digital platform for T2DM in British Columbia isn't just a website; it's a testament to the power of user-centered design and collaboration in transforming chronic disease management. By bringing resources together and fostering collaboration, it's already addressing key gaps in diabetes care. What we're most excited about now is sharing the detailed methodology outlined in our new publication.  We believe this transparent, step-by-step account offers a valuable blueprint. If you're looking to build similar essential digital health resources, our paper provides the foundation – from our literature review insights to our co-creation process and technical considerations. The journey from idea to a live platform has been incredibly promising. We invite you to explore the platform today, and for those ready to innovate, we hope our published process inspires and guides your next steps in creating impactful digital health solutions. Read our in press article here and tell us what you think in the comments below. Look out for the open access full article in August via the same link. Listen on your phone

Key Highlights ✅ Diabetes raises heart disease risk years before diagnosis ✅ Women face higher risk of silent heart attacks ✅ Early signs often go unnoticed -- screening matters ✅ Lifestyle changes can protect heart and delay T2D ✅ Prevention must start decades before diagnosis Did you know that most people with diabetes (65-80%) die from heart disease ? It's a sobering fact, highlighting a crucial link. If you have diabetes, especially if you're a woman, your risk of heart problems like atherosclerosis is higher and can start earlier. What's more, many heart attacks in people with diabetes can happen silently , without typical symptoms. In 2008/2009, close to 2.4 million Canadians , about 7% of the population, were living with diagnosed diabetes. Similarly, heart/cardiovascular disease (CVD) remains the second leading cause of death amongst Canadians, only surpassed by cancer, with a significant portion of the burden driven by preventable risk factors such as type 2 diabetes (T2D), obesity, hypertension, and smoking. Concerningly, people living with T2D are more than three times more likely to die of heart disease compared to those without diabetes. This link is well-established, as chronic hyperglycemia contributes to endothelial dysfunction, atherosclerosis, and inflammation, core mechanisms underlying CVD. But that's not the only system affected. Diabetes contributes to four out of ten heart attacks, three out of ten strokes, half of all kidney failure cases requiring dialysis, is the leading cause of blindness, and is responsible for seven out of ten non-traumatic leg and foot amputations. Stats from Diabetes Canada As the prevalence of T2D continues to rise in Canada , especially among younger adults and racialized populations, a proactive, population-level approach to cardiovascular risk assessment and lifestyle intervention is increasingly critical. Focus on T2D Heart Connection Let's hone in on the impact on the cardiovascular system, or rather, when this starts. It's a case of the chicken or the egg: is cardiovascular disease present before the diabetes diagnosis or does it result from the diagnosis? A groundbreaking nationwide registry study from Denmark, recently published in the Journal of the American College of Cardiology in December last year , has revealed that individuals who eventually develop T2D begin to experience significantly higher rates of CVD up to 30 years before their diabetes diagnosis. This large study, which included over 127,000 individuals with T2D and more than 381,000 matched population controls, found a consistent and substantial increase in cardiovascular events, defined as myocardial infarction or ischemic stroke, long before diabetes is ever diagnosed. People who eventually develop type 2 diabetes already have a much higher chance of having a heart attack or stroke many years before they’re diagnosed. In fact, even 25 to 30 years before being diagnosed, their risk is already more than twice as high as people who don’t get diabetes. As they get closer to diagnosis, their risk keeps going up. In the five years just before they’re diagnosed, their chance of having a heart-related event is nearly three times higher . And even after they’re diagnosed, their risk of heart problems stays high for at least the next five years. This study challenges the conventional clinical timeline in which cardiovascular risk management begins only once diabetes is diagnosed or prediabetes is identified. Instead, it underscores the reality that metabolic and vascular damage begins decades earlier , likely driven by underlying insulin resistance, inflammation, and other shared risk factors. Supporting Studies and Evidence We know that people with diabetes are at much higher risk of CVD, and this risk begins years before the diabetes is officially diagnosed. Scientists now also know this connection is not just due to high blood pressure or clogged arteries, there are direct effects of diabetes on the heart muscle itself. One of these effects is known as diabetic cardiomyopathy It refers to changes in how the heart looks and works in people with diabetes, even when there’s no history of coronary artery disease or high blood pressure. These changes often go unnoticed at first (asymptomatic), but over time they can lead to heart failure. The underlying mechanisms include oxidative stress, inflammation, damage to the cells lining blood vessels (endothelial dysfunction), and problems with how calcium is handled in heart cells. Understanding these processes can help us find ways to catch heart damage early and treat it effectively. A large study from the ASIAN-HF Registry examined the impact of type 2 diabetes (T2D) on individuals with heart failure, comparing those with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF). T2D was present in 40.2% of HFrEF patients and 45.0% of HFpEF patients. Additionally, diabetes was linked to a 27% higher risk of heart failure rehospitalization and a 22% increased risk of death or hospitalization within one year, regardless of heart failure type. These findings highlight the significant and consistent burden of T2D on heart structure , function, and clinical outcomes in patients with heart failure. Stats from Diabetes Canada Implications for Current Heart Guidelines and Screening Current national guidelines also reflect growing awareness of the need for early intervention, although they may not yet go far enough. Screening: What Works? While screening for heart disease sounds good, studies haven't yet proven that routine screening in asymptomatic individuals with diabetes significantly improves survival. However, if your doctor suspects heart disease, various tests can help. Stress tests , like exercise ECGs, are valuable for high-risk individuals to understand their prognosis. But remember, a significant number of people with diabetes who have heart disease won't experience chest pain. Other clues, like shortness of breath or an abnormal resting ECG, are important to watch for. An abnormal resting ECG, particularly with certain changes, is a strong indicator of silent heart issues, especially for women. Newer imaging, like Coronary CTA (CT angiography), can show heart artery disease early. If your Coronary CTA is normal, it's generally good news, suggesting a low risk of heart events for at least five years. Coronary Artery Calcium (CAC) scoring  is another strong predictor of future heart problems. While various tests like stress tests, Coronary CTA, and CAC scoring can help assess risk, current research doesn't definitively support routine screening for heart disease in asymptomatic (silent) individuals with diabetes to improve survival outcomes. Peripheral artery disease is also common in diabetes, and although checking pulses is a simple screening method, its diagnostic accuracy is limited despite its prognostic value. Type 1 diabetes also carries a substantially increased, and often earlier, risk of heart disease, with some studies suggesting women with type 1 diabetes may face an even higher ( two-fold) mortality risk from cardiovascular disease than men. Given these complexities, a personalized approach focusing on overall risk factor management rather than widespread asymptomatic screening is generally favored. Understanding these risks is the first step toward better heart health with diabetes. A Call for Earlier Action Healthcare providers should no longer view the diagnosis of T2D as the starting point for cardiovascular prevention, it’s already late in the game. Instead, risk assessments for CVD should begin much earlier in life , especially in those with family histories of diabetes, metabolic syndrome, or obesity. Patients , too, must be empowered to understand and track their cardiovascular risk factors from a younger age, including monitoring their blood pressure, cholesterol, waist circumference, and physical activity. Health systems and policymakers also have a role to play. Investment in population-level prevention strategies, including early screening and health education in schools and workplaces, could drastically reduce the long-term burden of both T2D and CVD. These strategies are particularly crucial in younger adults, whose risk may not yet be reflected in traditional screening models but whose future health could be shaped by interventions made now. What Can You Do Now? Preventing cardiac disease in T2D requires a multi-faceted strategy - we've gathered all the resources for you on our T2D Network website to help you though. A cornerstone of prevention involves lifestyle modifications , with extensive guidance on healthy eating  emphasizing fruits, vegetables, whole grains, and healthy fats, alongside limiting processed foods and red meats, which is linked to a reduced risk of obesity, heart disease, and certain cancers. Regular physical activity  is also crucial; recommendations from Diabetes Canada suggest at least 150 minutes of moderate-intensity aerobic exercise and two resistance exercise sessions per week, with evidence indicating that higher activity levels are associated with significantly lower morbidity and mortality in people with diabetes. Beyond lifestyle, aggressive management of traditional cardiovascular risk factors is essential. Blood pressure control  is paramount, with guidelines suggesting a target of less than 130/80 mmHg  for most people with diabetes and at risk for cardiovascular disease, acknowledging the continuous and graded association between BP and cardiovascular risk. Similarly, lipid management  through statin therapy is recommended for people with diabetes, with high-intensity statins for those with established cardiovascular disease, to reduce LDL cholesterol and thereby lower cardiovascular risk. Assess your cardiac risk here with the Canadian Cardiovascular Society recommended CardioRisk calculator. Starting the Clock Early Ultimately, we need to turn a spotlight on the hidden burden of cardiovascular disease in people on the path to diabetes. Recognize that prevention efforts must start not at diagnosis, but decades earlier . If we want to stop the clock on cardiometabolic disease, we have to start listening to its ticking much sooner. Join us to stay tuned for more evidence based T2D discussions. Listen to this blog on your phone

Key Highlights ✅ T2D diagnosis is a key opportunity for change ✅ Early lifestyle shifts prevent complications ✅ You’re not alone, millions live well with T2D ✅ Emotions matter, seek support if needed ✅ Shared decisions improve treatment success Receiving a Type 2 Diabetes (T2D)  diagnosis can feel overwhelming, but it's also a pivotal moment for your health. This initial period is often a window of opportunity where newly diagnosed patients are highly motivated to embrace lifestyle changes, which are a cornerstone of diabetes management. You are not alone.  T2D is one of the most common chronic conditions worldwide, affecting 1 in 9 people globally. Many have walked this path before you, and many have learned how to manage their diabetes effectively and live full, active lives. With the right information, tools, and support, you can do the same. The first few weeks after diagnosis can feel like a whirlwind of appointments, unfamiliar terms, and sudden lifestyle adjustments, but there is no need to make every change at once. Start with one or two achievable steps and build from there. It's normal to feel a mix of emotions . Some people feel angry, confused, or even ashamed after receiving a diagnosis. Others are relieved to finally have an explanation for symptoms like fatigue or frequent urination. Whatever you're feeling is valid, and it’s important to acknowledge those emotions. Diabetes management isn’t just about numbers; it's also about caring for your mental well-being. If you feel overwhelmed, talk to your provider or seek support from mental health services that understand the challenges of living with a chronic condition. Watch Mary's experience of being newly diagnosed with T2D. Navigating Type 2 Diabetes New Diagnosis - Your Voice Matters Research from leading diabetes associations like the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) consistently emphasizes a vital point: early, effective treatment can lead to a longer, healthier life and fewer complications. While pharmacotherapy is often recommended at the time of a T2D diagnosis, nearly 40% of patients discontinue medications within the first year . This isn't a failure, but rather highlights the critical need for shared decision-making  between you and your healthcare provider. Your preferences and circumstances are paramount in developing a personalized treatment plan that you can realistically adhere to. For individuals highly motivated to avoid medications and willing to commit to a structured lifestyle program, this approach can be beneficial. New technologies like Continuous Glucose Monitoring (CGM)  should also be considered. Although insurance barriers can exist, manufacturers are working to make these devices more accessible, including lower-cost over-the-counter options. The ADA recommends that such technologies be used with initial and ongoing training, education, and data monitoring to maximize their effectiveness. You have more power than you think. Learning what influences your blood sugar, whether it's a brisk walk or a specific food, can help you feel more in control - and motivated - to keep making changes that work for you. Beyond the Pill: The Power of Lifestyle Innovation One exciting development in lifestyle interventions is Glycemic Excursion Minimization (GEM) . Representing a paradigm shift, GEM is a lifestyle program that focuses on reducing post-meal glucose spikes rather than solely on weight reduction. GEM strategies focus on managing blood sugar spikes primarily through dietary adjustments , by replacing foods options. They also emphasize physical activity , particularly after meals, to help process glucose and enhance insulin sensitivity. This newer, less demanding intervention has shown remarkable promise for newly diagnosed T2D patients, particularly those with a BMI ≤ 30. In one study, GEM was associated with a mean A1c reduction of 1.8%  at 3 months, alongside significant improvements in BMI, diabetes distress, empowerment, and depressive symptoms. Notably, two-thirds of participants experienced diabetes remission  in this GEM study , and another study found GEM superior to weight loss therapy alone, with two-thirds of participants classified as responders after 12 months with a mean A1c reduction of 1.6% . GEM works by encouraging choices of low glycemic load foods and promoting skeletal muscle activity (even simple walking!) 1-2 hours after consuming moderate-to-high glycemic load foods. This helps to minimize BG elevations and hasten BG recovery. While individual responses vary due to factors like gut bacteria and insulin sensitivity, CGM can provide valuable visual feedback on how specific foods and activities impact your unique glucose levels, empowering you to make informed dietary and activity choices. Your care team is here to help.  Whether you're seeing a family doctor, a diabetes educator, a pharmacist, or a dietitian, these professionals can help you understand your blood glucose targets, explain your lab results, and help you prioritize initial changes to your eating habits, physical activity, and daily routine. Many clinics also offer group education classes or access to peer support networks, which can ease the learning curve and offer reassurance. The Game-Changing Role of Newer Medications For many individuals, medication remains a vital component of managing T2D and its cardiovascular risks. Newer drug classes, particularly GLP-1/GIP pharmacotherapy , are truly changing the landscape of T2D treatment. The latest addition to this class, tirzepatide, which targets both GLP-1 and GIP receptors, has demonstrated superiority over other GLP-1 receptor agonists in both glycemic management and weight loss. These "incretin hormones" (GLP-1 and GIP) are naturally released from the gut after you eat. They stimulate insulin secretion, especially after meals, and suppress glucagon (a hormone that raises BG levels). By slowing gastric emptying, they promote a feeling of fullness, leading to reduced calorie intake and weight loss. They also act on the brain to regulate appetite and satiety, supporting long-term weight management. Though gastrointestinal side effects (like nausea) are common, they are typically mild-to-moderate and often manageable with dietary adjustments, however, further research is needed on the long-term effects. Your Personalized Path to Health Ultimately, there is no single "best" treatment for everyone with T2D. The challenge, and the goal, is to find a treatment approach that best fits with what you are able and willing to embrace  at this point in your diabetes journey. There is no one-size-fits-all path.  Early in your diagnosis, you may hear advice from friends, online forums, or even well-meaning family members. While some of it might be helpful, it’s critical to remember that diabetes care is highly individual. Your cultural background, income, schedule, family responsibilities, and access to food or physical activity spaces all influence what "successful management" looks like for you. Don’t be discouraged by rigid plans that feel impossible to follow, instead, work with your team to co-create realistic goals based on where you are right now. The most effective treatment is one that is easy to implement and sustainable  for you. Frequent monitoring of your blood glucose is crucial regardless of your management decisions to ensure that any "therapeutic inertia" - a delay in adjusting therapy when treatment goals aren't met – is promptly addressed. Empower yourself with knowledge, visit the T2DNetwork website , actively participate in your treatment decisions, and work closely with your healthcare team to find the path that leads to your best health! Join us for more evidence based discussion Listen to the podcast version of this blog on your phone

Key Highlights: ✅ T2D is a complex, multisystem disease, no longer just about sugar. ✅ New meds protect the heart and kidneys while lowering glucose. ✅ Weight loss is now a core treatment goal, supported by lifestyle and meds. ✅ Mental health care and digital tools are essential parts of T2D management. ✅ Team-based, patient-centred care delivers better outcomes and support. Type 2 diabetes (T2D) used to be viewed primarily as a disorder of elevated blood glucose, and, indeed, glycaemic control remains foundational. But over the past decade, our understanding of T2D has expanded dramatically. We now recognize it as a complex, multisystem disease that affects the heart, kidneys, nervous system, mental health and more. T2D is predominantly influenced by phenotype  (environmental and lifestyle factors) rather than solely by genetics, in contrast to type 1 diabetes. This means that its origins are complex and extend beyond simple pancreatic dysfunction, involving broad physiological instability stemming from factors like diet, exercise, sensory input, and even vaccine exposure, rather than just a single biochemical pathology. Because of this, many experts advocate for a holistic view that recognizes T2D as a complex disorder stemming from systemic instability rather than isolated biochemical dysfunctions. Here’s how today’s comprehensive approach goes well beyond “just sugar.” 1. Cardiovascular and Renal Protection A comprehensive approach to T2D management extends far beyond simply controlling blood sugar levels; it critically encompasses the protection of vital organs, particularly the cardiovascular system and kidneys, which are highly susceptible to T2D-related complications. Modern therapeutic advancements have ushered in a new era where glucose-lowering medications also offer significant organ-protective benefits. For instance, the class of drugs known as SGLT-2 inhibitors has demonstrated remarkable efficacy in this regard. In the pivotal EMPA-REG OUTCOME trial , while empagliflozin did not significantly reduce rates of myocardial infarction or stroke compared to placebo, it remarkably led to a 38% relative risk reduction in cardiovascular death, a 35% reduction in hospitalization for heart failure, and a 32% reduction in death from any cause. This trial was a game-changer, establishing empagliflozin not merely as an antidiabetic agent but as a crucial cardiovascular therapeutic. Similarly, dapagliflozin, another SGLT-2 inhibitor, demonstrated significant reno-protective and cardiovascular benefits in the DAPA-CKD trial , where it significantly reduced the risk of kidney disease progression (defined as a substantial decline in kidney function or progression to end-stage kidney disease) and death from either renal or cardiovascular causes in patients with chronic kidney disease, irrespective of whether they also had diabetes. These aren't the only medications that patients with T2D often take. Due to the complexity of the disease and the associated co-morbidities, there are other drugs that offer protective benefits to vital organs. Here we summarize a few key classes. Drug Class Drug Mechanism of Action Cardiovascular Protection Renal Protection Common Indications SGLT2 Inhibitors Canagliflozin , Dapagliflozin , Empagliflozin Inhibits sodium-glucose co-transporter 2 (SGLT2), reducing glucose reabsorption in the kidneys, promoting glycosuria. Reduces the risk of cardiovascular death and hospitalization for heart failure in T2D patients ( EMPA-REG OUTCOME) Slows the progression of diabetic kidney disease (DKD) and reduces risk of end-stage renal disease (ESRD) (CREDENCE) T2D with established cardiovascular disease (CVD) or risk factors. GLP-1 Receptor Agonists Liraglutide , Semaglutide , Exenatide Mimics the action of glucagon-like peptide-1 (GLP-1), promoting insulin secretion, reducing glucagon release, and slowing gastric emptying. Reduces major adverse cardiovascular events (MACE) such as heart attack, stroke, and cardiovascular death ( LEADER Trial) May have reno-protective effects, including reducing albuminuria ( SUSTAIN-6 ) T2D with cardiovascular disease or risk of CVD. ACE Inhibitors Enalapril , Lisinopril , Ramipril Inhibits angiotensin-converting enzyme (ACE), leading to vasodilation, reduced blood pressure, and reduced aldosterone production. Reduces the risk of cardiovascular events by controlling blood pressure (HOPE Study) Slows the progression of diabetic nephropathy, reduces albuminuria ( IDNT Trial ) Hypertension and diabetic nephropathy in T2D. Angiotensin II Receptor Blockers (ARBs) Losartan , Valsartan , Olmesartan Blocks the effects of angiotensin II at the receptor site, leading to vasodilation and reduced blood pressure. Reduces the risk of cardiovascular events, including heart failure and stroke (ONTARGET Study) Reduces albuminuria and protects against kidney damage in T2D ( RASS Study ) Hypertension and diabetic nephropathy in T2D. Aldosterone Antagonists Spironolactone , Eplerenone Blocks the effects of aldosterone, reducing sodium retention, lowering blood pressure, and preventing fibrosis in the heart and kidneys. Reduces the risk of heart failure and cardiovascular mortality (EMPHASIS-HF Trial) Provides renal protection, especially in heart failure with preserved ejection fraction (HFpEF) (EPATH-CHF Study) Heart failure with T2D, hypertension, and diabetic nephropathy. Beta-Blockers Metoprolol , Carvedilol , Bisoprolol Blocks beta-adrenergic receptors, reducing heart rate and blood pressure, and decreasing the oxygen demand on the heart. Protects against heart failure and arrhythmias, especially in patients with ischemic heart disease. No direct renal protection but can reduce complications associated with hypertension. Hypertension, heart failure, and post-myocardial infarction. Diuretics (Thiazide/Loop) Hydrochlorothiazide , Furosemide Increases excretion of sodium and water from the kidneys, lowering blood pressure and reducing fluid overload. Reduces blood pressure, which can prevent cardiovascular events. Used in heart failure to manage fluid retention; may reduce kidney function if overused. Hypertension, fluid overload, and heart failure in T2D patients. Crucially, these benefits were observed even in patients without diabetes, underscoring the broad applicability of these agents for organ protection. This shift highlights a proactive and preventative strategy, recognizing that safeguarding the cardiovascular and renal systems is paramount in achieving truly comprehensive and life-extending T2D management. 2. Holistic Weight Management Weight reduction is no longer an optional “nice-to-have” in diabetes care, it’s a core pillar. An estimated 70.3% of new T2D cases globally (14.1 million) were directly linked to suboptimal dietary habits. The biggest culprits were not eating enough whole grains, consuming too much refined rice and wheat, and excessive intake of processed meats. The study also found that diet's impact on T2D varied by region, gender, age, and socioeconomic factors, and this dietary burden has significantly increased since 1990. In addition to lifestyle interventions, novel pharmacotherapies like dual GIP/GLP-1 agonists produce sustained, clinically meaningful weight loss. This dual focus on diet, exercise and adjunctive medications means we’re tackling insulin resistance and metabolic dysfunction at multiple levels. We recently had a discussion with Ian Patton from Obesity Canada - watch the teaser and view the full vodcast on our YouTube channel. 3. Mind-Body Integration: Mental Health Matters Depression and anxiety affect almost 28% and 14% respectively of people with T2D, worsening self-care and glycaemic control. Integrating behavioural health into diabetes clinics improves outcomes: a randomized trial found that patients receiving collaborative care (cognitive behaviour therapy [CBT] plus diabetes education) had significantly lower A1C and depressive symptoms at 12 months. Today’s best practices include routine screening for distress and on-site mental health support. Do you know that the BounceBack BC program, developed by the Canadian Mental Health Association (CMHA), is a free, evidence-based mental health program designed to help individuals aged 13 and older manage symptoms of mild to moderate depression and anxiety, as well as stress and worry. It is largely based on CBT principles, offering practical skills and techniques to improve mental well-being and build resilience. The program provides flexible access through three main avenues: telephone coaching with trained professionals who guide participants through skill-building workbooks, a self-guided online platform with interactive modules and videos, and a series of "BounceBack Today" videos offering practical tips on mood management, sleep, confidence, and healthy living. While the coaching component typically requires a referral from a primary care provider, the online program and videos are accessible without one, ensuring broad reach and timely support for those seeking to reclaim their mental health. 4. Continuous Monitoring & Digital Health Continuous glucose monitors (CGMs) and connected insulin pens have shifted care from snapshot lab values to real-time feedback. Studies consistently show reductions in glycosylated hemoglobin levels ranging from 0.25% to 3.0% , along with significant improvements in time in range by 15% to 34% . Telemedicine follow-ups, which boomed during the COVID-19 era, have maintained glycaemic outcomes while improving access, especially in rural or underserved areas. 5. Team-Based, Patient-Centred Care No single provider can address all facets of T2D. Today’s gold-standard model employs interprofessional teams, endocrinologists, diabetes educators, dietitians, pharmacists, mental health specialists and exercise physiologists, working together to tailor interventions. Shared decision-making tools ensure that each patient’s values and preferences drive the care plan, boosting adherence and satisfaction. In fact, team based care has been associated with greater reductions in blood glucose, blood pressure, and lipid levels. Putting It All Together In 2025, managing T2D means more than hitting an A1C target. It’s about protecting the heart and kidneys, supporting mental health, leveraging digital tools for personalized monitoring, and orchestrating a multidisciplinary team to deliver truly holistic care. Both patients and providers benefit when we see T2D through this wider lens, because optimal outcomes arise when we treat the whole person, not just their blood sugar. Join us to hear more T2D insights and stay tuned Listen to this blog on your phone:

Did you miss our July newsletter - sign up here and don't miss a beat! In July, we take time to reflect on two powerful events that continue to shape the world of health care. On July 27 , we commemorate the discovery of insulin  in 1921 , a groundbreaking Canadian innovation that transformed diabetes care. This discovery didn’t just save lives—it sparked decades of research, innovation, and advocacy for people living with diabetes. Today, as type 2 diabetes (T2D) continues to rise across all populations, this milestone feels more important than ever. Just one day later, on July 28 , we observe World Hepatitis Day , an international call to action to eliminate viral hepatitis as a public health threat. But here’s something many people don’t realize, chronic hepatitis, especially hepatitis C, is also linked to a higher risk of developing type 2 diabetes. Viral liver infections can contribute to insulin resistance and metabolic dysfunction, showing us why prevention, screening, and care must be better integrated. These back-to-back observances are a reminder that chronic diseases rarely exist in isolation. Whether it’s supporting someone at risk for diabetes, managing viral hepatitis, or pushing for equitable access to care, we're all part of a bigger picture—working together to build healthier futures. 👉 This month, we invite you to learn, reflect, and connect with us as we explore the link between liver health and diabetes and share practical tools for education and prevention. Project Update: South Asian Health Strategy in Surrey We’re excited to share some big strides from our work in Surrey. Our South Asian Health Strategy  is off to a strong start. ✅ A prototype diabetes screening clinic is now up and running, offering culturally tailored resources to support community members. ✅ We’ve held screening sessions at community centers across Surrey’s South Asian neighborhoods, with some sessions reaching up to 300 individuals . Everyone identified at risk was directly connected to health services for further care. This work is filling a critical gap. Surrey is home to nearly 474,000 people of South Asian descent , and many have been underserved when it comes to diabetes screening and education. We're making sure resources are relevant, respectful, and responsive to their needs. Did you know? A major study in BC found that South Asian people with long-term hepatitis C  were much more likely to develop T2D. For every 1,000 people, about 15 with hepatitis C developed diabetes annually, compared to 10 without the virus. In South Asians, the virus raised diabetes risk 2.6 times higher , a stronger link than in other ethnic groups. 👉 Learn more about this project and browse our South Asian–focused diabetes resources. UBCO Diabetes & Obesity Research Day On May 29, T2D Network Director Ed Smith attended the UBCO Obesity and Diabetes Research Day in Kelowna, BC . Hosted by the BC Diabetes Research Network, this annual event brings together researchers from both UBC campuses and other institutions to share the latest in diabetes and obesity research. One of our key goals at the T2D Network is to close the research-to-practice gap. Events like this are invaluable, they give us a chance to build connections, learn from leading scientists, and explore how new discoveries can translate into better care. Thanks again to the BC Diabetes Research Network for a powerful and inspiring event. We’re looking forward to the next one! Must-Watch: T2D Network’s Patient Partner Series Meet the people at the heart of diabetes care, those living with T2D . Our new Patient Partner Series  on YouTube gives the mic to real voices and lived experiences. In this playlist, you’ll hear honest conversations about daily struggles, victories, and everything in between. In one standout episode, Shelley Tice interviews Joy , a Patient Partner who shares her journey and the power of being involved in co-designing care. 🎥 Watch the full series here  and get a deeper look into what T2D really means, from the people who know it best. Mark Your Calendar: ATTD 2026 Conference Technology and innovation are shaping the future of diabetes care, and ATTD 2026  is where it all comes together. From March 11–14, 2026 , join global leaders in Barcelona, Spain , for the 19th International Conference on Advanced Technologies & Treatments for Diabetes . Expect cutting-edge updates on AI in healthcare, smart devices, digital tools, and next-gen therapies. 📝 Abstracts are due by September 10, 2025 . Whether you're a researcher, clinician, or innovator, this is the place to be for the future of diabetes care. Sign up here . Spotlight: Continuous Glucose Monitoring (CGM) With all the new advancements in insulin therapy, staying current with continuous glucose monitoring (CGM)  is essential, especially for Canadian healthcare professionals. CGM doesn’t just help manage diabetes, it can also reveal patterns that may point to underlying liver dysfunction . That’s why it’s important to view glucose data alongside hepatic lab results. CanadaCGM.com  is a great place to start. Topics include: CGM basics and product comparisons Updates on public coverage and health policy Clinical guidelines and virtual care best practices Managing hypoglycemia and interpreting CGM data Tools You Can Use: Interactive Diabetes Management Resources Making informed treatment decisions can be complex—but the right tools help. We’ve rounded up interactive online resources  to support health professionals managing type 2 diabetes. And don’t forget: if liver disease is suspected, be sure to check liver function. Some glucose-lowering drugs need dose adjustments or are contraindicated in active hepatitis. Check out these trusted tools: Diabetes Canada Decision Tool  – Helps you select appropriate medications, with a clear recommendation to use insulin for severe hyperglycemia. Compare T2D Drugs  – Side-by-side comparison of 24 drug classes, looking at A1C impact, weight changes, and hypoglycemia risk. Diabetes Medications Table  – A comprehensive overview of all medications used in diabetes care. 💡 Find these and more resources on our Interactive Tools webpage . New on the Blog: Hepatitis & Diabetes -- What You Need to Know Our latest blog post dives into the often-overlooked link between hepatitis and type 2 diabetes . It turns out that people with chronic hepatitis C face a significantly increased risk of developing T2D, especially in underserved communities. We break down the research, explain shared risk factors, and emphasize the need for integrated care and screening . If you work in healthcare, public health, or community outreach, this post is a must-read. 👉 Read the full blog post here . Stay Connected with the T2D Network The Type 2 Diabetes Network brings together healthcare professionals, researchers, patients, and organizations to improve T2D outcomes in BC. Led by the Institute for Health System Transformation & Sustainability , we share best practices, evidence-based tools, and innovative approaches to care. 📬 Want updates delivered to your inbox? Join our newsletter  and never miss an issue. Listen on your phone

Blog Highlights ✅ AI tools are outperforming doctors in some real-world cases. ✅ MAI-DxO, Microsoft AI tool, achieved 85.5% diagnostic accuracy. ✅ AI can reduce costs, improve early T2D detection, and boost health equity. ✅ AI’s impact on T2D care is especially significant in underserved areas. ✅ Though still in development, AI shows great potential to transform healthcare. Imagine a world where detecting type 2 diabetes (T2D) and its complications becomes faster, more accurate, and more equitable, powered by intelligent systems that support healthcare teams rather than replace them. With the rise of artificial intelligence (AI) in healthcare, these innovations may soon become a reality. The Challenge of Modern Healthcare The healthcare industry faces an urgent need for more efficient and accurate diagnostic tools. As demand for healthcare services grows and medical knowledge becomes increasingly complex, the ability to quickly and accurately diagnose conditions is more critical than ever. Misdiagnoses or delayed diagnoses can have life-altering consequences, yet many healthcare systems still rely on human physicians, who can be overwhelmed by the vast amounts of medical information available. AI offers a potential solution by providing tools that can analyze vast amounts of data and help clinicians arrive at more accurate diagnoses faster. Health Canada has gone so far as to outline Pan-Canadian AI for Health Guiding Principles to reinforce the transformative potential of AI in health. 👉 Before we go any further, let's recap the basics and explore what is AI? 👉  Can AI truly match or even surpass the expertise of human doctors? Introducing the Microsoft AI Diagnostic Orchestrator (MAI-DxO) To explore this question, the Microsoft AI team developed the Microsoft AI Diagnostic Orchestrator (MAI-DxO), an innovative AI system designed to assist in solving some of medicine’s most complex diagnostic challenges. Benchmarking this AI against real-world cases, they published their study and revealed some fascinating results. Analyzing 304 diagnostically challenging cases, MAI-DxO was able to correctly diagnose up to 85% of the cases, a rate more than four times higher than that of human generalist physicians. Additionally, the AI system was able to reach the correct diagnosis in a more cost-effective (20% cheaper) manner than its human counterparts. In a 2024 test similar to the one Microsoft performed using case studies, the earlier version of Google’s system accurately diagnosed 59% of cases, compared to human doctors’ rate of 33% . This marks a pivotal moment in healthcare, as AI begins to demonstrate the ability to not only keep pace with the expertise of physicians but also do so in a more efficient and cost-effective way. What Makes the MAI-DxO Different? Unlike other AI systems that rely on one-shot answers to multiple-choice questions, which are often used in medical exams like the USMLE (United States Medical Licensing Examination), MAI-DxO excels at sequential diagnosis. This method mirrors the real-world decision-making process of physicians, who begin with an initial patient presentation and use iterative reasoning to narrow down potential diagnoses.   It uses five distinct AI “agents” that work together in a collaborative manner, similar to a multidisciplinary healthcare team. These agents analyze the data and "debate" their findings, arriving at a diagnosis through consensus. One key feature that sets this system apart is its transparency, unlike many AI models that operate as "black boxes," the Diagnostic Orchestrator can explain its reasoning step by step. MAI-DxO can ask questions, review test results, and continually update its reasoning, just like a physician would in a clinical setting. By evaluating 304 recent NEJM cases, researchers were able to assess how AI performs when given the opportunity to refine its diagnostic approach over time. Image courtesy of Microsoft AI When tested on 304 real-world cases  of complex diagnoses, including diabetes-related complications, the tool outperformed human doctors in diagnostic accuracy. The AI was able to correctly diagnose 85.5%  of cases, compared to only about 20%  by physicians without access to additional references or decision-support tools. “We are nearing AI models that are not just a little bit better, but dramatically better, than human performance: faster, cheaper and four times more accurate,” - Mustafa Suleyman, CEO of Microsoft AI. Integrating AI into Practice A randomized control trial, " Large Language Model Influence on Diagnostic Reasoning: A Randomized Clinical Tria l," published in JAMA Network Open, investigated whether providing physicians with access to a Large Language Model (LLM) like ChatGPT Plus (GPT-4) improved their diagnostic reasoning compared to using only conventional resources (e.g., UpToDate, Google). The study found that physicians who had access to an LLM did not show a statistically significant improvement in their diagnostic reasoning performance when compared to physicians who only used conventional resources. Their median diagnostic reasoning scores were very similar (76% for the LLM group vs. 74% for the conventional group). Interestingly, when the LLM was tested on its own (without physician interaction), it scored significantly higher ( 92% median score) than both groups of physicians (with or without LLM access). Physicians plus LLM (the group with LLM access):  76% and physicians plus conventional resources (the control group):  74% . This suggests the LLM itself possesses strong diagnostic capabilities. While the LLM itself showed strong diagnostic capabilities, simply making it available to physicians without specific training on how to best integrate it into their workflow did not enhance their diagnostic performance. In another study published in JAMA Internal Medicine  compared physician and AI chatbot (ChatGPT) responses to patient questions on Reddit's r/AskDocs. The chatbot's responses were preferred in 78.6% of evaluations, being rated of higher quality and more empathetic than physicians' replies. The chatbot's answers were also longer, with a 3.6 times higher likelihood of being rated "good" or "very good" and 9.8 times more likely to be considered empathetic. The study suggests AI could assist in drafting responses for clinicians, potentially reducing burnout and improving patient care. Why This Matters for Diabetes Care T2D is a global health crisis . Despite the scale of the problem, diabetes remains underdiagnosed. Some US estimates note that 1 in 4 people  with diabetes are unaware they have it. The condition can develop insidiously, and by the time patients seek medical attention, complications may already be present. Early diagnosis is crucial to prevent devastating complications, but current diagnostic systems may not always capture the full complexity of the disease. Additionally, the rising cost of diabetes healthcare is one of the biggest challenges facing modern healthcare systems, particularly in Canada, where healthcare spending is approaching $30 billion annually . Much of this spending is driven by inefficiencies. AI could play a major role in reducing unnecessary healthcare expenditures. AI could have a profound impact on diabetes care in the following ways: Early Detection of Prediabetes and T2D AI systems can detect patterns in patient data that may elude human clinicians. Subtle signs like fatigue, weight fluctuations, and blurred vision, common in early-stage diabetes, can be analyzed across large datasets, improving the ability to detect diabetes in its earliest stages. According to a review published in May 2025 in the Journal of Diabetes Metabolic Disorder, early intervention can significantly reduce the risk of progression to full-blown diabetes, as well as the risk of complications. Complication Screening For individuals already diagnosed with T2D, early identification of complications such as cardiovascular disease, diabetic retinopathy, or diabetic nephropathy is critical. The AI-assisted retinal image analysis can prioritize screening for these complications based on patient-specific data, helping to ensure that at-risk patients are monitored more closely. This is especially important in resource-limited settings, where access to specialists and diagnostic tools may be constrained. Similarly, AI can help identify biomarkers for kidney disease and cardiovascular risk in diabetes patients. Cost Efficiency The ability to prioritize tests and screenings could lead to significant cost savings . For patients with limited access to healthcare or who face financial barriers to care, reducing unnecessary lab work and imaging tests is a key advantage. One study in the US developed an AI-driven decision model that allocated preventive treatments, such as metformin, to at-risk patients, resulting in potential savings of $1.1 billion annually for the U.S. healthcare system, based on electronic health records from 89,191 prediabetic patients. Showing that AI has the potential to reduce costs by improving diagnostic accuracy and facilitating earlier interventions. Health Equity AI tools could improve healthcare access and equity, particularly in rural and underserved communities. In these areas, frontline healthcare providers may lack access to specialized resources or expertise, leading to delays in diagnosis and suboptimal care. AI-powered diagnostic support could help bridge this gap by offering consistent, evidence-based insights and recommendations, ensuring that all patients, regardless of geography or socioeconomic status, receive high-quality care. In a study of 17,674 adults with diabetes, deployment of autonomous AI for diabetic eye disease (DED) screening at Johns Hopkins primary care sites significantly improved adherence to annual testing guidelines, with a 36% higher increase at AI sites compared to non-AI sites. Notably, AI implementation also improved access and health equity, with DED screening rates among Black/African American patients increasing by 11.9% and narrowing longstanding racial disparities in care. Dr. Dominic King from Microsoft describes the tool as a potential “new front door to healthcare,” one that could be especially valuable in the context of diabetes, where delayed or missed diagnoses are common and costly. What’s Next? While the Microsoft Diagnostic Orchestrator is still in its development phase, it has shown promising results in clinical trials. The tool will undergo further peer review and regulatory approval before it can be deployed in real-world clinical settings. Leading figures in the field, such have called the tool’s early results “landmark” in the field of healthcare AI. As AI continues to evolve, the potential applications in healthcare are virtually limitless. We’re not just talking about AI assisting in the diagnosis of common conditions like pneumonia or diabetes. The possibilities extend to rare diseases, complex medical cases, and even personalized medicine, where AI could analyze an individual’s unique genetic and medical history to recommend the most effective treatment options. While the current research demonstrates AI’s potential in improving diagnostic accuracy and reducing costs, we’re still in the early stages. More testing, validation, and regulatory oversight will be necessary before AI can be integrated into clinical practice. But the promise of AI in healthcare is undeniable, and we’re excited to continue pushing the boundaries of what’s possible. Final Thoughts For people living with type 2 diabetes, and the healthcare teams that support them, AI-powered diagnostic tools like the Microsoft Diagnostic Orchestrator could provide significant benefits. By improving diagnostic accuracy, reducing delays, and helping clinicians focus more on prevention and treatment, these tools have the potential to transform diabetes care. As healthcare increasingly embraces team-based, tech-enabled care, AI could play a pivotal role in closing the care gap for millions of people living with diabetes worldwide. For underserved populations, in particular, such technology could help deliver more equitable and accessible care, ultimately improving health outcomes and quality of life for those living with chronic conditions like T2D. Join the Conversation The future of AI in healthcare is just beginning. What are your thoughts on this new frontier? How do you think AI will impact your experience with healthcare in the years to come? Share your insights with us in the comments below and join us to stay updated!

Blog Highlights ✅ GLP-1 RAs manage blood sugar and support weight loss for T2D and obesity. ✅ Approved GLP-1 RAs in Canada include semaglutide, liraglutide, and dulaglutide. ✅ GLP-1 RAs reduce cardiovascular risks but may cause nausea and GI issues. ✅ GLP-1 RA use is rising among non-diabetics, raising concerns about misuse. If you’re living with type 2 diabetes   (T2D) or struggling with obesity , you may have heard about a new class of medications called GLP-1 receptor agonists (GLP-1 RAs). These drugs are making headlines for their ability to lower blood sugar and support weight loss — but what are they and how do they work? Let’s break it down. What are GLP-1 Receptor Agonists GLP-1 agonists (short for glucagon-like peptide-1 receptor agonists) are medications that mimic a hormone naturally produced in the gut. This hormone helps regulate blood sugar and appetite, especially after eating. When used as medication, GLP-1 RAs increase insulin production when blood sugar is high, reduce the amount of glucagon (a hormone that raises blood sugar), slow digestion, and increase feelings of fullness; all of which contribute to better blood sugar control and weight management. Most GLP-1 RAs are injectable, but oral options are also available, such as semaglutide tablets. These medications are primarily prescribed for people with T2D who need more than just metformin to control their blood sugar. They are also used for people living with obesity (defined as a body mass index, or BMI, of 30 or more) or overweight individuals (BMI of 27 or more) who have related health issues like high blood pressure or cholesterol. It’s important to note that GLP-1 agonists are not approved for use in Type 1 diabetes in Canada, although they may occasionally be prescribed off-label in unique circumstances. Which GLP-1s are approved in Canada ? Medication Brand Name(s) Use Frequency Approved in Canada? Dulaglutide Trulicity® T2D Weekly injection ✅ Yes Exenatide Byetta®, Bydureon® T2D Twice daily or weekly ✅ Yes Liraglutide Victoza® (T2D), Saxenda® (weight loss) T2D, Weight Management Daily injection ✅ Yes Lixisenatide Adlyxine® T2D Daily injection ✅ Yes Semaglutide Ozempic® (T2D), Rybelsus® (oral for T2D), Wegovy® (weight loss) T2D, Weight Management Once weekly (injection) or daily (oral) ✅ Yes (Wegovy approved in 2025) Tirzepatide Mounjaro® T2D (weight loss under review) Weekly injection ✅ Yes (Approved in 2024) Wegovy®, a higher dose of semaglutide used for weight loss, was recently approved by Health Canada. However, due to high global demand, access may be limited in some areas. What are the benefits? The benefits of GLP-1 RAs go beyond just lowering blood sugar. They can also improve other health markers such as blood pressure and cholesterol levels. Some studies suggest that they help reduce the risk of heart and kidney disease, support liver health (especially in people with fatty liver disease), and may delay the progression of diabetic kidney complications. A pivotal 2021 clinical trial of semaglutide  showed that participants lost an average of 15% of their body weight over 68 weeks, compared to just 2% in the placebo group. Some individuals even lost up to 20% of their initial weight. More recently, the potential health advantages of these drugs have expanded. Findings from the SELECT trial , published in 2023, revealed that semaglutide reduced the risk of heart attack and stroke by 20% in people with pre-existing cardiovascular disease. Across other large studies, GLP-1RAs showed consistent and significant health benefits beyond glycemic control. A comprehensive cohort study using U.S. Veterans Affairs databases  found that GLP-1RA use was associated with reduced risks of major adverse cardiovascular events (MACE), stroke, heart failure, cardiac arrest, and thromboembolic disorders. Neurocognitive benefits included a lower incidence of Alzheimer’s disease, dementia, and psychotic disorders such as schizophrenia. The same study also reported fewer cases of respiratory failure, pneumonia, substance use disorders, and seizures. These findings were echoed in a large-scale adjusted analysis involving 7 million person-years of data . Additionally, a meta-analysis of 26 trials concluded that GLP-1RAs were particularly effective in reducing macrovascular and microvascular complications, positioning them as a strong therapeutic choice for patients at risk of cardiovascular and cerebrovascular disease. What are the risks? As of 28 October 2024, the UK Government's med watch database (MHRA) received over 7,000 reports of gastrointestinal side effects linked to GLP-1RAs, with some resulting in hospitalization. Despite their benefits, GLP-1RAs carry several notable risks. Common ones reported by the Government of Canada include nausea, vomiting, diarrhea, and loss of appetite, especially when starting the medication or increasing the dose. Some people also experience headaches, dizziness, or mild injection site reactions. More serious but rare side effects include pancreatitis, kidney issues, allergic reactions, and possible thyroid tumors (seen in animal studies). These medications are not recommended during pregnancy, and they may increase the risk of hypoglycemia (low blood sugar) when used with insulin or sulfonylureas. Studies have noted higher rates of gastrointestinal disorders, hypotension, syncope, kidney stones (nephrolithiasis), interstitial nephritis, and drug-induced pancreatitis. These findings were confirmed by the observational analysis , which also reported increased musculoskeletal issues such as arthralgias and arthritis. Additionally, other studies have found an elevated risk of thyroid cancer in GLP-1RA users (odds ratio 1.58), further emphasizing the need for careful patient selection. Compared to alternate T2D drugs, GLP-1RAs have a unique adverse effect profile that necessitates individualized prescribing based on tolerability and risk factors. What happens if GLP-1 RAs are stopped? While GLP-1 RA drugs are effective, their high cost ( US$1,350/month) and side effects (nausea, stomach pain, heartburn) raise concerns, especially about what happens after stopping treatment. Numerous studies have investigated this question, and the results are consistent: weight often returns once treatment is stopped. In one trial , participants lost nearly 11% of their body weight with weekly semaglutide injections, dietary changes, exercise, and psychological counseling. However, when a third of the participants were switched to a placebo for the following year, they regained 7% of the weight they had lost. A similar trend was observed in the STEP 1 trial of 2021 . After 68 weeks on semaglutide, patients had lost an average of over 15% of their body weight. But within 12 months of stopping treatment, they regained two-thirds of the weight they had lost, along with a significant reversal of improvements in some cardiometabolic markers, such as those related to diabetes and heart disease. The pivotal 2021 clinical trial of semaglutide revealed that nearly 14% of participants were unable to lose even 5% of their body weight, despite being on the medication for over a year. And only around 10% of people were able to maintain all the weight they’ve lost. In another study , patients without T2D were more likely to stop using GLP-1 drugs: about 65% discontinued within a year, compared to 46% of those with type 2 diabetes. After two years, the discontinuation rates rise to 84% for non-diabetic patients and 64% for diabetics. The study highlights that those experiencing fewer side effects are less likely to quit, emphasizing the impact of tolerability and affordability on long-term use. For most, the weight returns quickly, typically within the first 3 to 6 months. This pattern mirrors what’s seen in other chronic conditions, where relapses occur once treatment stops. Understanding why weight regain happens after discontinuing GLP-1 treatment could be crucial for determining their long-term health impacts and the best way to prescribe them in the future. How are GLP-1 RAs Changing T2D Treatment Options Many patients have reported positive experiences with GLP-1 receptor agonists. For instance, those who were previously unable to control their blood sugar levels or face considerable weight challenges have found success with these medications. Patients often highlight the ease of use, GLP-1 receptor agonists can be administered via daily or weekly injections, depending on the specific medication. Additionally, many patients appreciate the positive side effects, such as weight loss, rather than severe drawbacks associated with some diabetes medications. However, these drugs appear to be having a wider impact than the physical state and are reshaping culture and society. An article by Matthew Schneier for New York Magazine  explores how the diabetes drug Ozempic, and similar medications, are transforming not just bodies, but the very culture and psychology of eating, thinness, and status. Laila Gohar (artist): “ Everyone in L.A. is skinny now... Well, the last few people who weren’t, now are .” Gohar notes the dramatic, visible impact of Ozempic on entire social scenes. The piece investigates how drugs like Ozempic, originally for diabetes, have become status symbols and appetite suppressants among the non-diabetic elite, especially in entertainment and fashion. Quotes from users, doctors, and cultural commentators reveal a landscape where weight loss is now quick, medicalized, and quietly omnipresent; reshaping not just bodies, but the meaning of food, self-control, and social status Dr. Holly Lofton (NYU Langone Health) details the overwhelming demand for these drugs, even among those not strictly medically eligible. “The last six months, I’ve written 1,400 prescriptions for semaglutide... They come in begging for it. If I give them pills, they’re disappointed. ” -- Lofton These social and cultural changes have increased demand, motivating illegal methods to obtain the drugs. The UK Government MHRA  warns against the misuse of falsified GLP-1RAs, often acquired without a prescription, and the growing trend of using these medications for aesthetic weight loss. Healthcare providers should stress that these drugs should only be obtained from authorized sources and used under medical supervision. Nevertheless, GLP-1 drugs are skyrocketing in popularity even in those without T2D. A 2024 study published in The BMJ reports a staggering 700% increase in the number of U.S. adults without diabetes who began GLP-1RA treatment between 2019 and 2023. According to researchers from the University of Pennsylvania and Cedars-Sinai Medical Center, the number of non-diabetic patients starting these medications jumped from 21,000 in 2019 to over 174,000 in 2023. Using data from over 45 million de-identified patient records, the team found that more than 870,000 people were prescribed a GLP-1RA between 2011 and 2023. Notably, nearly two-thirds of these users did not have diabetes, and the majority ( 59.6% ) were women. The growing demand for pharmacological tools to support weight loss, beyond traditional lifestyle interventions, reflect a broader shift in how these powerful medications are being used in clinical practice. The Future of Diabetes Care with GLP-1 RAs The landscape of diabetes care continues to evolve, and GLP-1 RAs are at the forefront of this transformation. With ongoing research, new formulations, and combination therapies on the horizon, patients can expect even more innovative options for managing their diabetes. Advancements in technology, such as connected pen caps t hat track medication use and integrate data with smartphone applications, will enhance patient engagement and adherence. Increased awareness about the benefits and accessibility of GLP-1 RAs will also play a significant role in diabetes management moving forward. As we look ahead, it is evident that GLP-1 RAs are revolutionizing diabetes care. Their ability to improve blood sugar control, facilitate weight loss, and significantly impact cardiovascular health sets these medications apart as vital tools in diabetes management. As demand and options are shaped by GLP-1 RAs, a growing need for support is becoming evident . Support groups and communities, like the glp-1 forum , provide patients with a platform to share their experiences and learn from others. This shared knowledge can empower patients in their diabetes management journey. Understanding and utilizing GLP-1 RAs alongside a balanced lifestyle can empower individuals to take control of their diabetes. The integration of technology, community support, and evidence-based medication will shape the future of diabetes care, ensuring better outcomes for patients worldwide. Join our network for more information on T2D.

Blog Highlights ✅ Hepatitis C significantly increases the risk of type 2 diabetes. ✅ The liver plays a central role in blood sugar regulation. ✅ Shared risk factors affect underserved populations most. ✅ Coexisting hepatitis and T2D lead to worse health outcomes. ✅ Integrated screening and care can improve patient outcomes. July hosts the World Hepatitis Awareness day on July 28th each year. But when most of us think about hepatitis, we picture liver disease. When we think about type 2 diabetes (T2D), we think about sugar, insulin, and diet. But what if these two conditions are more connected than you think? The surprising link between liver disease and blood sugar problems isn’t just a scientific curiosity, it has real-life implications for millions of people around the world, including here in Canada. Why this Connection Matters Emerging research highlights a significant interplay between hepatitis and T2D, particularly within the Canadian healthcare landscape. For healthcare professionals, recognizing this connection is crucial, as it can shape patient care, treatment strategies, and public health approaches. This blog explores how these conditions are linked, the risk factors they share, and what it means for integrated healthcare. Understanding Hepatitis and T2D Hepatitis is inflammation of the liver, most commonly caused by viral infections (like hepatitis A, B, and C), alcohol use, or autoimmune diseases. In Canada, an estimated 387,000 individuals live with chronic hepatitis C, according to Catie . This substantial number highlights the importance of awareness and screening for hepatitis. What are the types of hepatitis - find out in this short snip from the Mayo Clinic. T2D, meanwhile, is a metabolic disorder where the body becomes resistant to insulin, leading to elevated blood sugar levels. It can result in serious complications, including heart disease and kidney failure. With the growing prevalence of T2D in Canada, understanding its connection to liver health is more important than ever. The Liver–Glucose Connection The liver plays a central role in regulating blood glucose by storing glucose as glycogen and releasing it when needed. It also influences insulin sensitivity and fat metabolism. In cases of chronic liver inflammation, such as hepatitis B or C, this delicate balance is disrupted. Over time, the liver can become insulin resistant, and its ability to manage glucose and lipids deteriorates - raising the risk of developing T2D. What the Research Shows Numerous studies have identified a strong link between chronic hepatitis C virus (HCV) infection and T2D: A meta-analysis found that people with HCV are 1.7 times more likely to develop diabetes than those without the virus. Up to 33% of people with chronic HCV also show evidence of glucose abnormalities, including impaired fasting glucose and insulin resistance. In populations with high rates of HCV, such as people who inject drugs, the rates of T2D are significantly elevated, suggesting a double burden of disease. HCV is believed to trigger insulin resistance through both direct viral effects on liver cells and through the production of pro-inflammatory cytokines, which interfere with insulin signaling pathways. Additionally, HCV infection is associated with hepatic steatosis (fatty liver), which further increases insulin resistance. The relationship between hepatitis B virus (HBV) and T2D is less pronounced than with HCV, but it still exists. Some population-based studies have found a moderate increase in diabetes risk among individuals with HBV. Outbreaks of HBV in long-term-care facilities were notably linked to adults with diabetes. In North America, people with HBV have been observed to have higher rates of T2D compared to the general population. But hope is not lost - people with hepatitis are making changes in their communities to improve health outcomes. Hear how Shabana is making an impact in Yorkshire. Shared Risk Factors: Why Some People Face Both Both hepatitis and T2D often affect similar groups, especially underserved populations. Factors like socioeconomic status, race, and limited access to healthcare can increase the likelihood of developing both conditions. The most common risk factors for hepatitis B and C include sharing drug-use equipment (needles, straws, pipes), unprotected sex, being born in or to someone from a region where the virus is common, and exposure to contaminated medical or personal items. Hepatitis C can also be transmitted through re-used tattooing or piercing tools and, in rare cases, unscreened blood transfusions or organ transplants, especially before 1990 in Canada or more recently in other countries. Many key risk factors for T2D , such as obesity, non-alcoholic fatty liver disease (NAFLD), and certain social determinants of health, overlap with those for hepatitis B and C, including injection drug use, unprotected sex, and exposure to contaminated equipment; this shared risk environment contributes to a higher co-occurrence of these chronic conditions, especially in marginalized populations. The Double Burden: Living with Hepatitis and Diabetes Having both hepatitis and T2D can significantly increase the risk of liver-related and cardiovascular complications. People with both HCV and diabetes are more likely to develop advanced fibrosis and cirrhosis. One study found that people with HCV and diabetes had a 3-fold higher risk of hepatocellular carcinoma (HCC) compared to those with HCV alone. Diabetes can worsen treatment outcomes in patients receiving antiviral therapy for hepatitis. The liver plays a central role in metabolizing glucose and fats. When hepatitis causes inflammation in the liver, its function can deteriorate, leading to insulin resistance and, ultimately, T2D. Additionally, hepatitis C has been closely associated with insulin resistance, creating a cycle where reduced liver function negatively affects metabolic health. A Public Health Priority: Why Screening Matters According to the World Hepatitis Alliance , more than 350 million people worldwide are living with viral hepatitis, and most don’t even know it. Meanwhile, T2D continues to rise globally, affecting more than 537 million adults as of 2021, a number expected to hit 643 million by 2030, according to the IDF. In Canada, the burden of hepatitis is disproportionately high among certain populations - including people who use drugs, Indigenous communities, newcomers, and individuals in prison. These same groups often face barriers to diabetes care, compounding the risk of poor outcomes. That’s why integrated care models are essential. These overlapping vulnerabilities point to the need for integrated care. Programs that test and treat for hepatitis should also screen for diabetes - and vice versa. Organizations like CATIE  are leading the way in promoting this kind of holistic care approach, recognizing that people don’t experience health conditions in silos. Clinical Implications While hepatitis and T2D require distinct treatment plans, integrated care strategies can be beneficial. For instance, direct-acting antivirals (DAAs) for hepatitis C have demonstrated improved metabolic outcomes in patients with T2D . By considering a patient’s overall health, healthcare providers can develop tailored treatment plans. Clinicians should screen for T2D in people with chronic hepatitis—especially HCV or advanced liver disease. Hepatitis screening should be considered for people with unexplained liver issues or known diabetes. Community health programs should combine hepatitis services with diabetes care and harm reduction. Hepatitis B vaccination is recommended for people with diabetes by public health authorities in Canada and globally. A New Perspective on Patient Care The connection between hepatitis and T2D is significant and often underestimated in the Canadian healthcare system. By acknowledging shared risk factors, biological relationships, and understanding clinical implications, healthcare professionals can implement more effective interventions. As we acknowledge that 28 July is World Hepatitis da y, and work toward addressing both hepatitis and T2D, collaboration among healthcare systems, organizations, and communities is essential. Focusing on prevention and early detection in high-risk groups will ultimately lead to better health outcomes for all Canadians. Recognizing the link between hepatitis and T2D in Canada is vital for countless individuals' health. This understanding can shape a healthier future for our communities and the healthcare system as a whole. Join us for more discussions on T2D

Blog Highlights ✅ DAC co-designs workshops with diverse Patient Partners. ✅ Themes, sessions, and menus reflect lived experiences. ✅ Patient Partners are co-presenters, judges, and awardees. ✅ Facilitators trained in inclusive, patient-centered approaches. ✅ A new model for inclusive, patient-led healthcare events. Have you ever been to a conference or meeting where you felt like your voice truly mattered? Where the people organizing it genuinely considered your experiences and perspectives? That's the kind of environment Diabetes Action Canada (DAC) has been cultivating in their workshops, and it's making a real difference in how we approach diabetes research and care. For the team at DAC, it's not just about gathering researchers and healthcare professionals. They understand that to truly make an impact, you need to involve the people who live with diabetes every single day – the Patient Partners . And their approach to doing this is pretty remarkable, as highlighted in a recent publication that looked at their best practices for planning in-person events. A group photo from the DAC 2024 Workshop. Think about planning an event. Usually, it's a small group behind the scenes deciding on the theme, the speakers, the schedule. But at DAC, they flip that script right from the start. They believe that the very foundation of a successful workshop lies in making sure everyone feels connected to the topic. So, when they start thinking about the theme, it's not just an internal decision. They make sure it's something that resonates with everyone who will be there, especially the Patient Partners. This ensures that right from the get-go, the workshop feels relevant and meaningful to those most affected by diabetes. Then comes the crucial step of putting together the team that will actually shape the event – the Workshop Planning Committee. Now, many organizations might invite a patient or two to sit on this committee. But DAC goes further. They actively recruit a diverse group of Patient Partners, ensuring representation across different ages, experiences with type 1 and type 2 diabetes, and even linguistic and cultural backgrounds, including Francophone and Indigenous voices. This committee isn't just there for show; they have real influence. They're involved in everything from selecting the presentations to even deciding what's on the menu! Imagine going to a conference where the food options were actually discussed with patients to ensure they meet dietary needs and preferences – it's these thoughtful details that make a huge difference. And speaking of making sure everyone can participate, DAC really walks the talk when it comes to support. They understand that attending an academic event can sometimes be a financial or logistical hurdle for Patient Partners. So, they cover all the attendance costs. But it's more than just paying for things. They create a clear and accessible "Things to Know" document that explains everything – travel, expenses, compensation for their time – in plain language, so there are no surprises or misunderstandings. They also create specific opportunities for Patient Partners to actively contribute and be recognized. Take their Patient Partner Award, for example. It's a way to honor the incredible contributions these individuals make to advancing diabetes research and care. And during the workshops, Patient Partners aren't just passive listeners. They're co-presenters in almost every session, sharing their lived experiences and insights alongside researchers. They even take on compensated roles like judging presentations and sharing their experiences on social media. This isn't just about having patients in the room; it's about valuing their expertise and making sure their voices are heard loud and clear. Creating an inclusive environment goes beyond just inviting people. DAC actively works to break down barriers. When they put out the call for presentations, they make sure the process is clear and accessible to everyone, even those who might be new to academic settings. They even hold information sessions and create FAQs to guide potential presenters. And here's a simple but powerful step: they tag abstracts submitted by Patient Partners for reviewers, ensuring those perspectives are specifically considered. They also make sure that presentations can take various forms – oral, poster, even artistic – recognizing that people communicate in different ways. Before the actual workshop, DAC goes the extra mile to prepare everyone for meaningful engagement. They hold facilitator training sessions, sharing best practices on inclusive language, facilitation techniques, and communication strategies, all based on what Patient Partners themselves have said would help them participate fully. They also ensure all workshop materials and presentations are available in both French and English, recognizing Canada's bilingualism. Even something as seemingly small as providing food menus in advance is a big deal for people managing diabetes, allowing them to plan their medication and meals effectively. And the menus themselves? Co-designed with Patient Partners to include healthy and varied options. They even make sure meal times are strictly adhered to, understanding the importance of timing for insulin doses. Once the workshop is underway, DAC continues to prioritize creating spaces where Patient Partners feel comfortable and confident in sharing their perspectives. Having a dedicated Director of Patient Engagement is key. This person is a consistent point of contact, someone Patient Partners can turn to for guidance and support, especially important for those who might be new to these kinds of events or traveling alone. The pre-workshop social dinner is another fantastic initiative. It's an informal setting where Patient Partners, key staff, and researchers can connect and build relationships before the main event. This helps to break the ice and create a more welcoming atmosphere. And during the workshop itself, those twice-daily check-in sessions provide a dedicated space for Patient Partners to connect with each other, ask questions, and offer feedback in real-time. It's also a way for the DAC team to check in on everyone's well-being. Finally, DAC actively works to "flatten the hierarchies" that can sometimes exist in academic settings. At the opening of the 2024 workshop, the Tracy McQuire , Executive Director, focused on sharing personal details rather than just professional titles, making themselves more relatable. They also encouraged everyone to use first names, and even the name tags only included first and last names, minimizing assumptions based on roles or affiliations. It's these conscious efforts to create a level playing field that truly make Patient Partners feel like valued equals. This isn't just about running a successful workshop; it's about fundamentally changing how research is done and how healthcare is delivered. By truly partnering with patients, DAC is not only creating more inclusive and impactful events but also paving the way for a more patient-centered future in diabetes care. Read the Patient Partners as Agents of Change - 2024 Workshop Report DAC - Published article on patient partnership Join us for more news on T2D

Key Highlights: ✅ Social prescribing shifts the focus to “What matters to you?” ✅ It connects individuals with personalized, non-medical community supports. ✅ Link workers play a vital role in guiding patients to local programs and resources. ✅ Social prescribing reduces loneliness, improves mental health, and supports chronic disease management. In healthcare, we often ask, "What's the matter with you?" But what if we asked a different question: "What matters to you?" This subtle but powerful shift in perspective is at the heart of social prescribing , an innovative approach to health that focuses on addressing the whole person, not just their physical symptoms. Social prescribing is gaining ground across Canada as a model that connects patients with non-medical resources in their communities to improve overall well-being. What is Social Prescribing? At its core, social prescribing is about broadening the traditional medical model. Rather than offering a prescription for medications or treatments alone, healthcare providers can now offer non-medical prescriptions: activities, community programs, or social services tailored to a person's interests and needs. These prescriptions can involve anything from joining an exercise group, attending support groups, participating in art classes, or volunteering at local organizations to combat loneliness and improve mental health. The key is that these activities are personalized, reflecting the individual’s values, preferences, and life circumstances. Social prescribing encourages people to engage with their community and improve their health in a way that resonates with them personally, empowering them to take charge of their well-being. A link worker  or community navigator plays a crucial role in social prescribing. This individual helps connect the patient with the appropriate community resources, offering guidance and support throughout the process. The integration of link workers in healthcare systems is a promising development in the Canadian healthcare landscape, which has been historically fragmented and overburdened by staffing shortages and lengthy wait times. Listen how Srija Biswas , the project lead from Canadian Institute for Social Prescribing ( CISP ), describes what social prescribing is and why it's important. The Benefits of Social Prescribing While the term social prescribing may sound relatively new, its principles are deeply rooted in holistic health approaches that have existed for decades. Recent studies have shown that social prescribing significantly enhances well-being, especially for individuals dealing with mental health issues and chronic diseases. In fact, the growing body of research supports the idea that addressing social determinants of health, such as social isolation, access to education, housing, and employment, can have just as profound an effect on health as medical treatment itself. For example, in Canada, where over 4 million individuals lack access to primary care , social prescribing has the potential to alleviate pressure on an overburdened healthcare system. Social prescribing empowers patients to be proactive about their health, potentially reducing healthcare costs  by addressing the root causes of illness before they require expensive medical interventions. A study examining the impact of social prescribing on individuals with depression showed that non-medical interventions like group activities, peer support, and exercise classes led to improved mental health outcomes, including increased self-esteem and confidence. As social prescribing gains traction, it could play an essential role in chronic disease management. For patients with conditions like type 2 diabetes, research has found that incorporating lifestyle interventions, social support, and mental wellness programs can help improve disease management and even reduce the need for pharmaceutical treatment. However, the support provided through social prescribing must match the persons needs to be effective. Social prescribing works by offering a comprehensive approach that complements conventional treatments, supporting individuals in living healthier, more fulfilling lives. The Voices Behind Social Prescribing The impact of social prescribing is best illustrated by the voices of those who are directly involved in it. CISP has created a video series called " Voices of Social Prescribing " that features testimonials from healthcare providers, link workers, and community partners. These individuals are on the frontlines, helping to connect patients with the resources and activities they need to improve their health. Bridging Health and Society In a 2025 article titled " Bridging Health and Society: Transforming Canadian Health Care Through Social Prescribing, "  the authors emphasize that social prescribing is more than just a trend. It is a fundamental shift in how healthcare professionals view and treat their patients. The article illustrates this shift with a poignant example: C.J., a 17-year-old female patient, attends a primary care clinic to discuss her depressive symptoms. Instead of immediately prescribing medication, the physician connects C.J. with a link worker, who takes the time to learn about her interests. After hearing about her passion for dance, the link worker prescribes dance classes and connects her to a youth support group. This approach not only addresses C.J.’s mental health but also promotes physical activity and social engagement, leading to positive changes in her overall well-being. Scenes like these might seem far removed from Canada’s healthcare reality, but they are already happening in countries like the UK , where social prescribing has been successfully implemented for years. As Canada faces a healthcare crisis , with an aging population, rising rates of chronic diseases, and an overwhelmed healthcare system, social prescribing offers a holistic solution to address health inequities and create more accessible, person-centered care. The Role of Link Workers Central to social prescribing’s success are link workers. Link workers  are integral to social prescribing, offering personalized support to individuals by focusing on their needs, interests, and goals. Shifting the conversation from "What's the matter with me?" to "What matters to me?", they connect people to community resources that address broader social factors impacting health. Their work strengthens community resilience, reduces health inequalities, and boosts active involvement in local activities. By building trust and providing ongoing support, link workers help create personalized pathways to wellness that go beyond medical care. Their efforts not only r educe repeat visits to primary care and emergency departments but also improve the sustainability of community programs. In essence, link workers play a vital role in fostering holistic, patient-centered care that emphasizes long-term, meaningful change. A study "Bridging Health and Society"  notes that link workers could play a key role in chronic disease prevention and recovery. For example, in patients with multiple sclerosis, greater social support was linked to a reduction in both physical and psychological burdens. The presence of community support proved similarly beneficial for individuals living with type 2 diabetes. These findings underscore the importance of addressing mental health and social support networks alongside physical health in the treatment of chronic conditions. Link workers can also help ease the burden on physicians, allowing them to focus on medical treatments while linking patients to the broader social support systems they need. In Canada, this approach could be a critical factor in reducing burnout among healthcare providers. The College of Family Physicians of Canada has identified burnout as a significant issue , with over half of general practitioners reporting feelings of exhaustion and stress. By integrating link workers into primary care settings, healthcare providers could focus more on the clinical side of care while relying on community support workers to address social needs. Tackling Mental Health and Chronic Disease with Social Prescribing Social prescribing has proven to be particularly effective in addressing mental health concerns, which are on the rise in Canada. One case study highlighted in the article discusses the story of Anna, who struggled with depression and severe isolation. She was referred to a community gardening group by her physician. Through this activity, Anna not only found joy in gardening but also gained the confidence to pursue a job application that had previously seemed daunting. Similarly, a woman in rural Canada who had recently relocated after becoming a widow found herself struggling with depression. After being referred to a community food program, she gained both companionship and a sense of purpose, eventually taking on a leadership role within the program. These stories highlight the transformative power of social prescribing, showing how community-based activities can foster mental health and self-esteem. For patients managing chronic diseases like diabetes, heart disease, or arthritis, social prescribing can complement traditional medical treatments by promoting healthy lifestyle changes and fostering social connections. Studies have shown that patients who engage in community-based programs experience improved health outcomes, including better disease management and reduced healthcare costs. Challenges and Solutions for Social Prescribing in Canada While the benefits of social prescribing are clear, there are challenges to its widespread adoption in Canada. Rural communities face logistical difficulties such as limited transportation and fewer community spaces, which can make it harder for patients to access social programs. Socioeconomic barriers also prevent many from participating in social prescribing activities, as vulnerable populations may struggle with transportation costs, childcare, or other challenges. However, these challenges are not insurmountable. Solutions include partnering with local organizations to provide transportation or hosting events in accessible community spaces. Additionally, programs like 211 , a free and confidential helpline, can connect patients directly with community resources without requiring a link worker. Healthy Aging Alberta  has developed training programs for link workers, ensuring that they are equipped to navigate these challenges and offer personalized care that addresses the social determinants of health. The Future of Social Prescribing in Canada As more Canadian healthcare providers, policymakers, and community organizations embrace social prescribing, we can expect to see a shift toward more holistic, patient-centered care. This shift could significantly improve the health outcomes of individuals, reduce healthcare costs, and alleviate the strain on an overstretched healthcare system. For social prescribing to truly flourish, it’s essential that healthcare professionals, policymakers, and communities work together to integrate this approach into everyday practice. From training link workers to supporting community initiatives, there’s much to be done to ensure that this promising model reaches its full potential in Canada. The key to success will be collaboration between healthcare providers, community organizations, and patients themselves. By focusing on the whole person and their unique needs, social prescribing can help create a healthier, more connected society. Getting Involved: Resources for Health Providers and Communities If you’re a healthcare provider or a community leader looking to get involved, there are plenty of ways to dive in. The Alliance for Healthier Communities  offers a variety of resources, including online training modules  and a social prescribing community portal. These resources are designed to help teams start or enhance their social prescribing programs and ensure that they’re inclusive and effective. The Canadian Institute for Social Prescribing  also offers comprehensive guides, including a Link Worker Competency Framework  and an educators guide, to help healthcare providers integrate social prescribing into their practices. Additionally, both organizations host events, webinars, and workshops to foster collaboration and support learning. Whether you’re just starting to explore social prescribing or you’re already deep into a project, there’s a wealth of knowledge and community to tap into. Stay tuned for more interesting insights from the T2D Network

Diabetes Canada is thrilled to unveil the recipients of its prestigious End Diabetes Awards, a yearly competition aimed at revolutionizing the lives of individuals affected by type 1 and type 2 diabetes through innovative research endeavors. With each winning project receiving a substantial $100,000 grant annually for three years, Diabetes Canada has committed a total of $6.2 million to fuel groundbreaking research initiatives within the diabetes community. Laura Syron, President and CEO of Diabetes Canada, emphasizes the organization's dedication to leveraging the combined power of technological, medical, and scientific research to realize a world free from the burdens of diabetes. Since its inception in 1975, this grant competition has positioned Canada as a global frontrunner in pioneering research efforts focused on enhancing diabetes screening, treatments, and care ─ ultimately benefiting the approximately 12 million individuals in Canada grappling with diabetes or prediabetes. Spanning various realms of biomedical, clinical, health services, and population health research, each winning project holds the promise of unraveling new insights and breakthroughs in diabetes management, care, and risk mitigation. Here are some standout projects from this year’s competition: 1. Dr. Ian Zenlea leads a research endeavor exploring community-based type 2 diabetes prevention interventions tailored to Black, African, and Caribbean communities, who face heightened risks of diabetes and related complications. 2. Dr. Joseph Gordon and his team investigate the potential of a muscle cell protein, Nix, in protecting against insulin resistance and mitigating changes associated with the onset of diabetes among younger demographics. 3. Dr. Nicole Woods spearheads a project aimed at enhancing the prevention and early treatment of diabetes-related foot wounds among structurally disadvantaged Ontarians living with diabetes. 4. Dr. Rayzel Shulman pilots a diabetes awareness campaign targeting elementary school educators, caregivers, and healthcare providers, equipping them to recognize signs of diabetes and diabetes ketoacidosis in children for timely intervention. The selection process for Diabetes Canada’s End Diabetes Awards involved rigorous evaluation by diabetes research experts, informed by input from individuals with lived experiences and Diabetes Canada’s National Research Council. Dr. Brandy Wicklow, Co-Chair of Diabetes Canada’s National Research Council, underscores the indispensable role of research in informing evidence-based care and transforming the lives of those grappling with diabetes. For nearly five decades, Diabetes Canada has been at the forefront of supporting exceptional diabetes research in Canada, channeling over $160 million into research grants, awards, and partnerships to fuel the fight against diabetes. The organization expresses profound gratitude to its generous community of donors whose steadfast support enables impactful investments in diabetes research, ultimately enhancing the health and well-being of individuals affected by diabetes nationwide. With over 260 researchers supported across 20 different research institutions, Diabetes Canada remains steadfast in its commitment to driving innovative research initiatives that hold the potential to transform the landscape of diabetes care and management. To learn more about this year’s groundbreaking research projects, visit Diabetes Canada’s website. Full article posted on Diabetes Canda Website Jan 22, 2024

Are you looking for reliable information and support to manage type 2 diabetes effectively? Look no further! We're thrilled to announce the launch of the T2D Network YouTube Channel , your ultimate destination for all things related to type 2 diabetes. What is the T2D Network? The T2D Network is a collaborative initiative with the Institute of Health System Transformation and Sustainability (IHSTS) dedicated to improving outcomes for individuals living with or at risk of type 2 diabetes across British Columbia. As part of our commitment to empowering individuals with knowledge and resources, we've created this YouTube channel to provide valuable insights, practical tips, expert interviews, and inspiring stories to help you on your diabetes journey. What Can You Expect? On the T2D Network YouTube Channel , you'll find a wide range of engaging and informative content, including: Expert Interviews: Gain insights from leading healthcare professionals, researchers, and advocates in the field of diabetes care. Educational Videos: Learn about the latest advancements in diabetes management, including medication, diet, exercise, and lifestyle modifications. Join Our Community We invite you to join our growing community of individuals who are passionate about diabetes care and management. Subscribe to the T2D Network YouTube Channel today and be the first to access our latest videos. Don't forget to hit the notification bell to stay updated on new uploads and live events. Have a Topic You'd Like Us to Cover? At the T2D Network, we're committed to addressing the topics that matter most to our audience. If you have a specific question or topic you'd like us to cover in an upcoming video, feel free to leave a comment on any of our videos or reach out to us directly. Your feedback is invaluable to us, and we're here to support you every step of the way. Stay Connected In addition to our YouTube channel, be sure to follow us on social media for more diabetes-related content, community updates, and behind-the-scenes glimpses. Connect with us on LinkedIn and Twitter to join the conversation and stay connected with our vibrant community.

The South Asian Women's Type 2 Diabetes Round Table, held on October 27, 2023, stands as a pivotal initiative in the collaborative efforts of the  Canadian India Network Society (CINS)  and the Institute for Health System Transformation and Sustainability (IHSTS) .  This third session underscored the urgency of addressing the significantly elevated risk of type 2 diabetes among South Asian Canadians, particularly focusing on the crucial role of women within this demographic.  ​ With cultural nuances influencing health decisions and behavior change across generations, South Asian women grapple with multifaceted challenges in managing their own diabetes amidst familial responsibilities and societal expectations. The round table, structured as an online focus group, provided a platform for eight participants to share their lived experiences, contributing to a nuanced understanding of barriers, challenges, and potential solutions.  The outcomes of this session not only shed light on the diverse and complex landscape of type 2 diabetes within the South Asian Canadian population but also furnish actionable insights for tailoring diabetes care strategies.  As we delve into the comprehensive summary, the round table emerges as a vital step toward redefining approaches to diabetes prevention, self-management, and alleviating the burdens faced by South Asian women in their healthcare journey. Read the full report here.

In the ever-evolving landscape of diabetes management, there's a pivotal shift underway, particularly when it comes to older adults grappling with Type 2 diabetes. By navigating the labyrinth of diabetes management with scientific rigor and compassionate insight, Iliana and Wade invite us to reimagine the paradigm of care for older adults with type 2 diabetes, fostering a future where personalized, holistic interventions reign supreme. At the heart of their discourse lies a stark reality: the staggering prevalence of diabetes among older adults and its cascading impacts. But instead of dwelling solely on the challenges, they wielded knowledge like a beacon, guiding us through the uncharted waters of diabetes management in the elderly. Central to their message was the concept of deprescribing—a strategic departure from the dogma of relentless medication escalation. This departure is crucial, especially in light of the interplay between diabetes and frailty, a symbiotic relationship that demands a nuanced approach. Gone are the days of rigid treatment targets; instead, Iliana and Wade championed a paradigm shift towards tailored care, one that takes into account not just blood sugar levels but also the individual's frailty and functional status. It's a holistic approach, recognizing that one size does not fit all in the realm of diabetes management. As Iliana and Wade eloquently put it, it's time to move beyond the shackles of overtreatment and embrace a future where each patient's journey with diabetes is as unique as they are. So, here's to a future where empowerment, not overtreatment, reigns supreme—a future we're one webinar closer to realizing. ✨ Highlights 💫 Introduction In this insightful webinar, we delve into the intricate realm of reducing overtreatment in type 2 diabetes, with a keen focus on the challenges and nuances faced by older adults grappling with this condition. The discussion unfolds to unveil the imperative need for deprescribing or de-intensifying medications to mitigate harm and enhance the quality of life for these individuals. We bring to light the evidence-based rationale behind deprescribing while furnishing practical examples and guidelines for tailoring medication regimens to diverse patient scenarios. 💫 Setting the Stage: Kathleen Chouinor , the CEO of IHSS and the Type 2 Diabetes Network, inaugurates the webinar, heralding a profound discussion on diabetes management. Participants are reminded of the importance of privacy and confidentiality in the chat, while IHSTS's noble mission of catalyzing transformative healthcare change sets the tone for the enlightening discourse ahead. [00:00]( https://www.youtube.com/watch?v=AKXY_6Gvymk&t=0 ) 💫 Understanding the Landscape: Iliana unveils the grim reality faced by older adults with diabetes, elucidating their heightened susceptibility to comorbidities and adverse outcomes. Geriatric syndromes cast a looming shadow over their quality of life, underlining the imperative for tailored, holistic approaches to diabetes management that account for individual variability. [06:51]( https://www.youtube.com/watch?v=AKXY_6Gvymk&t=411 ) 💫 Navigating Hypoglycemia Risks: The discussion pivots to the menacing specter of hypoglycemia haunting older adults with diabetes, particularly exacerbated by certain medications. Iliana meticulously dissects the data, spotlighting the alarming correlation between insulin, sulfonylureas, and hospitalization rates, underscoring the urgent need for vigilant medication review and adjustment. [13:43]( https://www.youtube.com/watch?v=AKXY_6Gvymk&t=823 ) 💫 Tailoring Treatment Approaches: Iliana and Wade advocate for a personalized approach to medication management and deprescribing in individuals with low A1C levels and other pertinent factors. Wade navigates through the intricate considerations involved in simplifying regimens, stressing the paramount importance of ongoing medication reassessment in light of evolving health statuses and circumstances. [20:32]( https://www.youtube.com/watch?v=AKXY_6Gvymk&t=1232 ) Embracing Deprescribing: Delving deeper into the realm of deprescribing, Wade elucidates its nuanced, patient-centered ethos, rooted in holistic health assessments and goal alignment. While acknowledging the paucity of robust evidence, he champions deprescribing as a feasible, safe strategy poised to optimize patient well-being without compromising clinical outcomes. [27:26]( https://www.youtube.com/watch?v=AKXY_6Gvymk&t=1646 ) 💫 Mitigating Overtreatment: Wade navigates the labyrinth of medication adjustments, shedding light on strategies to mitigate overtreatment risks while preserving glycemic control. From tapering risky medications to vigilant monitoring and tailored follow-up, he unveils a roadmap to strike a delicate balance between therapeutic efficacy and patient safety. [34:18]( https://www.youtube.com/watch?v=AKXY_6Gvymk&t=2058 ) 💫 Case Studies in Context: Wade also elucidates the theoretical underpinnings with real-world case studies, underscoring the pragmatic application of deprescribing principles in optimizing patient outcomes. From nuanced medication adjustments to personalized interventions, each case study serves as a beacon of hope in the quest to alleviate the diabetes burden in older adults. [41:11]( https://www.youtube.com/watch?v=AKXY_6Gvymk&t=2471 ) 💫 Holistic Considerations: The discourse culminates in a holistic exploration of diabetes management, transcending pharmacological interventions to embrace lifestyle modifications and proactive sick-day management. Iliana and Wade underscore the pivotal role of diet, cautioning against a one-size-fits-all approach and advocating for tailored dietary interventions in concert with medication adjustments. [48:01]( https://www.youtube.com/watch?v=AKXY_6Gvymk&t=2881 ) Enter the engaging webinar, "Reducing Overtreatment in Type 2 Diabetes," where experts, Iliana and Wade, illuminated a path towards more personalized and effective care.

Welcome to the T2D Network, where we prioritize a holistic approach to healthcare built upon four strategic foundational pillars and key priorities. At the core of our foundational structure lies patient engagement, where we empower individuals to actively participate in their healthcare decisions, establishing advisory roles and work nodes for impactful activities. Our commitment extends to linking communities seamlessly, aligning prevention activities, and focusing on knowledge translation to bridge the gap between community agencies and healthcare services. Additionally, we prioritize connecting diverse systems and populations , fostering collaboration between organizations, communities, and populations to enhance overall health outcomes. Together, these pillars form the foundational structure of our mission to create a patient-centered, community-driven healthcare ecosystem that continually advances through collaboration and innovation. As an organization, our strategic priorities are centered around exploring new avenues for innovation, engaging with stakeholders at all levels, enabling access to comprehensive healthcare resources, and expanding our reach to ensure equitable care for all individuals and communities. Through our commitment to exploring, we diligently investigate, trial, and translate health research to ensure effective application within our communities. By fostering active participation and collaboration , we engage stakeholders to drive community health improvement initiatives. Our dedication to enablement involves developing infrastructure and promoting behaviors that support preventive health measures and innovations. Lastly, our goal to expand involves extending partnerships , knowledge, and services nationally to broaden our health impact. Together, these priorities form the foundation of our efforts to prevent diabetes and promote healthier communities. At the T2D Network, we are committed to making strides in diabetes prevention and improving overall community health. Join us in our mission as we work together to build a healthier future for generations to come.

Welcome to the official T2D Network Blog – your go-to source for all things related to Type 2 diabetes research, innovation, and collaboration. As a collaborative group of healthcare professionals, researchers, organizations, and institutions, we are dedicated to addressing the challenges posed by Type 2 diabetes and improving outcomes for individuals across British Columbia. Led by the esteemed Institute for Health System Transformation & Sustainability (IHSTS) , our network is driven by a shared mission: to share, develop, and apply innovative practices that make a tangible difference in the lives of those living with Type 2 diabetes. We understand the complexities of managing this condition and recognize the importance of coming together to find holistic solutions. Through this blog , we aim to keep you informed about the latest advancements in Type 2 diabetes research, as well as the innovative initiatives being undertaken by members of our network. From groundbreaking studies to community outreach programs, we'll delve into the diverse range of efforts aimed at combating this pervasive health issue. But our blog isn't just about sharing information – it's also a platform for fostering dialogue and collaboration. We invite you to join the conversation by sharing your insights, experiences, and ideas. Whether you're a healthcare professional, researcher, advocate, or someone living with Type 2 diabetes, your voice matters, and we want to hear from you. Together, we can work towards a future where Type 2 diabetes is better understood, effectively managed, and ultimately prevented. So, stay tuned for engaging content, thought-provoking discussions, and inspiring stories as we journey towards a healthier, diabetes-aware British Columbia. Welcome to the T2D Network Blog – where knowledge, innovation, and collaboration intersect to make a real difference in the fight against Type 2 diabetes.

Are you ready to take charge of your health and prevent diabetes before it becomes a serious issue? Whether you're a healthcare professional or an individual concerned about your well-being, diabetes screening is a crucial step towards a healthier future. With THE CANADIAN DIABETES RISK QUESTIONNAIRE - CANRISK , it's easier than ever to assess your risk and take proactive measures. For Healthcare Professionals As healthcare professionals, we understand the importance of early detection and intervention in preventing chronic diseases like diabetes. By recommending the CANRISK screening tool to your patients, you're empowering them to make informed decisions about their health. CANRISK provides a simple yet comprehensive questionnaire based on established risk factors, enabling you to quickly identify individuals at risk of developing type 2 diabetes. With this valuable information, you can initiate timely interventions such as lifestyle modifications or referral to specialized care, ultimately reducing the burden of diabetes-related complications on individuals and healthcare systems. For the Public Are you concerned about your risk of developing diabetes? Take the first step towards a healthier future by visiting the CANRISK website. This user-friendly tool is designed to assess your risk of Type 2 diabetes based on factors such as age, family history, physical activity, and diet. By answering a few simple questions , you'll receive personalized feedback on your risk level and practical recommendations for reducing your risk. Whether it's making healthier food choices, increasing physical activity, or scheduling regular check-ups with your healthcare provider, CANRISK empowers you to take control of your health and make positive changes before it's too late. Why Choose CANRISK? Accessibility : The CANRISK website is readily accessible to anyone with an internet connection, making it convenient for individuals to assess their risk from the comfort of their homes. Accuracy : Developed by leading experts in diabetes research, CANRISK is a scientifically validated tool that provides reliable risk assessments tailored to individual profiles. Empowerment : By understanding your risk factors for diabetes, you can take proactive steps to prevent or delay its onset, leading to better health outcomes and improved quality of life. Don't wait until it's too late . Visit the CANRISK website today and take the first step towards a healthier future. Your health is in your hands, and CANRISK is here to help you every step of the way.

Diabetes is a significant health concern in Canada, affecting over 3 million individuals , or 8.9% of the population. This chronic condition comes in various forms, with type 2 diabetes comprising 90% of cases , followed by type 1 diabetes at 9%, and gestational diabetes at less than 1%. Despite advancements in healthcare, the prevalence of diabetes continues to rise, with an annual increase of 3.3% . One notable aspect of diabetes is its disproportionate impact on certain communities . Racialized and marginalized groups are at a heightened risk of developing diabetes, reflecting broader health disparities within society. Furthermore, the COVID-19 pandemic has exacerbated these disparities , amplifying the challenges faced by individuals with diabetes and hindering access to essential care. 2021 marked the 100-year anniversary of the discovery of insulin, a groundbreaking achievement that revolutionized diabetes treatment and saved countless lives. In recognition of this milestone, the Government of Canada allocated $35 million towards diabetes research and prevention initiatives. This funding aims to bolster efforts to address diabetes and enhance support for individuals living with the condition. The National Framework for Diabetes Act , enacted in 2021, represents a significant step forward in diabetes management and prevention. This framework focuses on improving access to diabetes prevention and treatment services nationwide, with input from stakeholders across various sectors. It encompasses six key components, including prevention, management, research, surveillance, knowledge sharing, and access to diabetes devices and financial support . The framework is essential for guiding coordinated efforts to tackle the complex challenges of diabetes in Canada. By emphasizing principles like health equity and collaboration, it provides a roadmap for addressing prevention, management, and treatment of diabetes. Through research and innovation, the framework aims to drive advancements in diabetes care , while comprehensive data collection and surveillance ensure evidence-based decision-making. Additionally, the framework prioritizes access to essential resources and support services, aiming to reduce disparities and improve health outcomes for individuals living with diabetes nationwide. Moving forward, it is imperative to continue advancing efforts to combat diabetes and promote better health outcomes for all Canadians. By prioritizing prevention , enhancing access to care , and fostering collaboration among stakeholders, we can work towards a future where diabetes no longer poses a barrier to overall well-being.

The Global Diabetes Compact framework is a collaborative initiative led by the World Health Organization (WHO) to address the rising global burden of diabetes affecting over 420 million people worldwide. It aims to mobilize international action and resources to scale up prevention, diagnosis, treatment, and care for diabetes, particularly in low- and middle-income countries where the disease prevalence is rapidly increasing. The Global Diabetes Framework underscores the significant impact of diabetes on health , highlighting the risks of complications such as heart disease and early mortality . The COVID-19 pandemic has further worsened these challenges, disrupting diabetes services and increasing severe cases among those with diabetes. The Compact aims to reduce diabetes risk, ensure equitable access to treatment, and prevent type 2 diabetes through obesity, unhealthy diet, and physical inactivity. It presents eight key asks, including uniting stakeholders, integrating diabetes care into primary health systems, and improving access to diagnostics and medicines. Three cross-cutting features emphasize the importance of insulin access, resilient health systems, and meaningful engagement of individuals with diabetes. Through partnerships with governments, civil society, and the private sector, the compact seeks to implement evidence-based interventions, strengthen health systems, and improve access to affordable diabetes care, ultimately working towards the Sustainable Development Goal target of reducing premature mortality from noncommunicable diseases by one-third by 2030. Overall, the Compact calls for global collaboration to alleviate the burden of diabetes and its complications, emphasizing comprehensive strategies and targets for prevention, treatment, and care.

Type 2 diabetes is a significant contributor to severe health conditions, including heart attacks, stroke, kidney failure, blindness, and lower-limb amputation. Tobacco use plays a crucial role in exacerbating these complications. Research indicates that quitting smoking can substantially reduce the risk of developing type 2 diabetes by 30–40% and improve its management. Considering that over 95% of diabetes cases are type 2, addressing tobacco use becomes paramount in preventing associated health issues. Smoking not only elevates the risk of cardiovascular disease, a critical complication for people with type 2 diabetes but also exacerbates diabetic neuropathy, foot ulcers, and delays wound healing. Furthermore, it damages retinal blood vessels, increasing the risk of diabetic retinopathy and vision loss. Quitting tobacco is instrumental in mitigating these risks and promoting better long-term health outcomes. Additionally, tobacco use and exposure to second-hand smoke can precipitate the onset of type 2 diabetes at an earlier age. Therefore, governments should prioritize implementing smoke-free policies in all indoor public places to safeguard their populations. To combat tobacco-linked diabetes morbidity, population-level interventions are essential. The World Health Organization (WHO) offers tools like the WHO Framework Convention on Tobacco Control (FCTC) and the Global Diabetes Compact to reduce tobacco demand and enhance diabetes prevention and management. Implementing effective tobacco control measures not only reduces tobacco use-related morbidity and mortality but also aids in achieving global health targets. Moreover, there is evidence to suggest that heavy use of smokeless tobacco and emerging nicotine and tobacco products like e-cigarettes and heated tobacco products increase the risk of developing type 2 diabetes. Therefore, further research is necessary to understand their impact fully. Preventing type 2 diabetes morbidity associated with tobacco use requires a comprehensive approach. Health-care providers should raise awareness about the harmful effects of tobacco use in relation to type 2 diabetes and promote cessation support. WHO recommends population-level interventions such as brief advice, toll-free quit lines, mCessation, QuitNow, chatbots, and pharmacological interventions to ensure comprehensive cessation support. Importantly, smoking cessation is associated with reduced cardiovascular risk and mortality among smokers with type 2 diabetes. Despite limited data on the effectiveness of tobacco control interventions for people with type 2 diabetes, interdisciplinary collaboration among health-care professionals is vital in implementing evidence-based strategies for behavior change in diabetes management. Therefore, it is imperative to encourage individuals with type 2 diabetes to refrain from tobacco use as part of their overall health management. Read more about this in the WHO Tobacco Knowledge Summary

Welcome to our latest blog post, where we delve into a pressing public health concern: the growing epidemic of diabetes among indigenous populations in Canada . In this post, we explore a recent systematic review titled 'The Growing Epidemic of Diabetes Among the Indigenous Population of Canada,' published in March 2023, which sheds light on the escalating prevalence of diabetes and its disproportionate impact on indigenous communities. Diabetes is not only a health issue but also a complex interplay of genetic, socioeconomic, cultural, and environmental factors. Understanding these complexities is essential for developing effective prevention and management strategies tailored to the unique needs of indigenous populations. The study was conducted in response to several compelling factors: Rising Prevalence of Diabetes : Diabetes is becoming increasingly prevalent among indigenous populations in Canada. Despite existing intervention efforts, rates of diabetes continue to rise, indicating a pressing need for a comprehensive understanding of the issue and effective preventive measures. Disproportionate Impact : Indigenous communities in Canada are disproportionately affected by diabetes compared to the general population. Understanding the underlying reasons for this disparity is essential for developing targeted interventions and reducing health inequalities. Cultural Relevance : Traditional approaches to health and wellness may not always align with mainstream healthcare practices. Culturally appropriate interventions are crucial for effectively addressing health issues within indigenous communities. Therefore, the study aims to identify culturally relevant strategies for diabetes prevention and management. Healthcare Costs and Burden : Diabetes imposes a significant financial burden on both individuals and healthcare systems. Indigenous populations may face additional economic challenges, exacerbating the impact of diabetes on their communities. Understanding the economic implications of diabetes is vital for advocating for resources and support for indigenous populations. The importance of preventing type 2 diabetes (T2D) cannot be overstated. T2D is a chronic condition associated with serious complications, including cardiovascular disease, kidney failure, blindness, and lower limb amputations. Preventing T2D not only improves individual health outcomes but also reduces the strain on healthcare systems and improves overall community well-being. These communities are at heightened risk of developing T2D due to a combination of factors: Genetic Predisposition : Indigenous populations may have a genetic predisposition to diabetes, making them more susceptible to the condition. Socioeconomic Factors : Indigenous communities often face socioeconomic disparities, including lower income levels, reduced access to healthcare services, and limited educational opportunities. These factors can contribute to unhealthy lifestyle behaviors, such as poor nutrition and physical inactivity, which increase the risk of T2D. Cultural and Environmental Factors : Historical and cultural factors, such as the loss of traditional land and dietary practices, may contribute to the increased prevalence of T2D. Additionally, environmental factors, such as limited access to healthy food options and geographic isolation, can further exacerbate the risk of T2D. Healthcare Disparities : Indigenous communities may experience barriers to accessing quality healthcare, including language barriers, mistrust of healthcare providers, and inadequate healthcare infrastructure. These disparities can impede timely diagnosis and management of T2D, leading to poorer health outcomes. This systematic review highlights the disproportionate impact of diabetes on Indigenous peoples and emphasizes the critical need for culturally appropriate interventions. Despite existing health programs, the prevalence of diabetes continues to rise, posing significant challenges to community well-being. By exploring the reasons behind this trend and the unique risk factors faced by Indigenous populations, these researchers uncover invaluable insights crucial for designing effective prevention strategies and providing essential support to these communities. The value of this research for indigenous communities lies in its potential to inform targeted interventions and policies aimed at preventing and managing T2D. By understanding the underlying factors contributing to the increased prevalence of T2D in these communities, policymakers, healthcare providers, and community leaders can develop culturally relevant strategies to promote health and wellness . Additionally, by highlighting the economic burden of T2D, this research can advocate for increased resources and support for indigenous populations, ultimately improving health outcomes and reducing health disparities.

Cutting-edge research from Queen Mary University London has shed light on a genetic variant prevalent in South Asian individuals, significantly impacting the accuracy of the HbA1c test, a cornerstone in diabetes diagnosis and management. In a study led by Dr. Miriam Samuel and her team, genetic data from over 60,000 individuals of Bangladeshi or Pakistani descent in England, alongside data from the UK Biobank comprising 500,000 participants of diverse ethnic backgrounds, was meticulously analyzed. Key Findings 1. Genetic Variant Prevalence : The study unearthed a genetic variant present in 7.6% of South Asian individuals, contrasting sharply with its rarity in other ethnic groups. 2. Impact on HbA1c Accuracy : Individuals carrying this variant may receive HbA1c results underestimating their average blood sugar levels by up to 6 mmol/mol. This discrepancy arises due to alterations in red blood cells, directly influencing test outcomes. 3. Delayed Diabetes Diagnosis : Evidence suggests that individuals harboring the variant face delayed diagnosis of type 2 diabetes by one to two years, potentially impeding timely intervention and management. Dr Miriam Samuel at Queen Mary University London reflects: “Many genetic variants linked to red blood cell conditions are ultra-rare amongst the Northern Europeans who have historically dominated genetic studies. We demonstrate one such variant that is carried by 7.6% of South Asians which could affect the accuracy of HbA1c and cause delays in diabetes diagnosis. Studies such as Genes & Health, focusing on populations who are underserved in genetic research, are vital to understand the different pathways that may contribute to diabetes inequalities in these communities.” Implications The implications of these findings are profound, particularly given the significant South Asian diaspora in England. With over 2.3 million individuals of South Asian descent living with Canada, 16% of which have diabetes according to Diabetes Canada , the impact of inaccurate HbA1c results cannot be overstated. Furthermore, this research underscores the imperative for diverse representation in genetic studies to elucidate nuanced health disparities among different ethnic groups. Moving Forward The study advocates for a nuanced approach to diabetes screening in South Asian populations, emphasizing the necessity of complementary tests, such as fasting glucose and oral glucose tolerance tests, to ensure accurate diagnosis and optimal management. In conclusion, this groundbreaking research serves as a clarion call for precision medicine approaches tailored to the unique genetic makeup of diverse populations, fostering equitable healthcare outcomes for all. This research will be presented at the Diabetes UK Conference

Managing Type 2 Diabetes (T2D) can be challenging, but with the right resources and support, patients, healthcare providers, and researchers can navigate this journey more effectively. Diabetes Canada stands out as an invaluable resource, offering comprehensive information, guidelines, and tools tailored to meet the diverse needs of the T2D community. Whether you are newly diagnosed, a healthcare professional seeking the latest guidelines, or a researcher exploring innovative solutions, Diabetes Canada has something for everyone. Explore their offerings here. A Closer Look at Type 2 Diabetes T2D is a growing concern globally, affecting millions of people. In Canada, the statistics are staggering: Approximately 3.6 million Canadians are living with diabetes, and of these, 90% have T2D. Each year, more than 200,000 Canadians are diagnosed with diabetes. Diabetes costs the Canadian healthcare system an estimated $3.8 billion annually, a figure expected to rise as the prevalence of diabetes increases. Given these figures, the need for reliable, evidence-based information and resources is critical. This is where Diabetes Canada comes in. For Patients: Empowerment through Knowledge Living with T2D requires ongoing management and lifestyle adjustments. Diabetes Canada offers a wealth of resources designed to empower patients: Educational Materials: Easy-to-understand guides, including Managing your Diabetes and T2D Overview , to help you manage your blood sugar levels, diet, and exercise. Support Networks: Access to local support groups and online communities to connect with others who share similar experiences. Tools and Apps: Virtual diabetes program , recipes , risk assessments , and self-care tips to help track blood sugar levels, medications, and daily activities. These resources are designed to help patients take control of their health and improve their quality of life. For Healthcare Providers: Staying Ahead with the Latest Guidelines Healthcare providers play a crucial role in managing T2D, and staying updated with the latest clinical guidelines is essential. Diabetes Canada provides: Clinical Practice Guidelines: Regularly updated guidelines that reflect the latest research and best practices in diabetes care. Continuing Education: Workshops, webinars , podcasts, professional membership , and conferences to help healthcare providers stay informed about new treatments and management strategies. Patient Management Tools: Resources such as treatment algorithms, patient education handouts, and monitoring tools to enhance patient care. These tools help healthcare providers deliver the best possible care to their patients. For Researchers: Advancing the Frontiers of Diabetes Research Research is the cornerstone of advancing diabetes treatment and management. Diabetes Canada supports researchers through: Funding Opportunities : Grants and fellowships for innovative research projects. Collaboration Networks: Platforms to connect with other researchers and share findings. By fostering a collaborative research environment, Diabetes Canada contributes to groundbreaking discoveries that can transform T2D care. Your Go-To Resource for Type 2 Diabetes Diabetes Canada is more than just an organization; it's a lifeline for patients, healthcare providers, and researchers. By providing access to top-notch resources, support, and information, they are making a significant impact in the fight against Type 2 Diabetes. Whether you are looking to manage your condition better, provide the best care, or contribute to groundbreaking research, Diabetes Canada is your go-to resource. Visit their website to explore all that they have to offer and join the community dedicated to improving the lives of those affected by T2D.

NHS Diabetes Prevention Efforts: An Overview The National Health Service (NHS) in the UK has been actively working on diabetes prevention for several years through various initiatives and programs. Diabetes, particularly type 2, poses a significant health challenge , affecting millions of people in the UK. The NHS's approach focuses on early intervention, lifestyle changes, and community support to mitigate the risk of developing type 2 diabetes. The Healthier You: NHS Diabetes Prevention Programme The cornerstone of the NHS's diabetes prevention strategy is the " Healthier You: NHS Diabetes Prevention Programme " (NDPP). Launched in 2016, this nine-month program targets individuals at high risk of developing type 2 diabetes. The program provides personalized support to help participants manage their weight, adopt healthier eating habits, and increase physical activity. This comprehensive lifestyle intervention has shown to reduce the risk of developing type 2 diabetes by more than a third. Recent Research and Data Recent data highlights the effectiveness of the NDPP. Participants who complete the program show significant improvements in their health metrics, including weight loss and reduced blood sugar levels. According to a review by Public Health England, diabetes prevention programs like the NDPP can reduce new cases of type 2 diabetes by up to 26% . Moreover, ongoing research and pilot studies have refined the program's approaches, ensuring that interventions are both evidence-based and tailored to the needs of diverse populations. For instance, the integration of digital health solutions, such as the Liva Healthcare platform, has expanded access to the program, making it easier for participants to receive support through smartphone apps. Historical Context and Evolution The NHS's focus on diabetes prevention dates back several decades, with early efforts primarily centered around awareness campaigns and education. However, the growing prevalence of type 2 diabetes necessitated more structured and scalable interventions. The establishment of the NDPP marked a significant shift towards proactive, community-based prevention strategies. Initially rolled out in select areas, the program has now expanded nationwide , with thousands of individuals benefiting each year. The success of the NDPP has also led to the development of complementary initiatives, such as the NHS Digital Weight Management Programme , which supports individuals in managing their weight through d igital tools and resources. Broader Impact and Future Directions The NHS's diabetes prevention efforts have broader implications for public health. By reducing the incidence of type 2 diabetes, these programs help alleviate the burden on healthcare services and improve overall population health. The success of the NDPP also serves as a model for other public health initiatives aimed at preventing chronic diseases through lifestyle modifications. Looking ahead, the NHS aims to enhance these programs by incorporating new technologies and expanding partnerships with community organizations and healthcare providers. Continuous evaluation and adaptation of the program will ensure it meets the evolving needs of the population and addresses emerging health challenges. Comparison with Diabetes Canada and the US YMCA Diabetes Prevention Program Diabetes Canada has implemented similar prevention initiatives, focusing on community-based education and support. The Diabetes Canada program emphasizes healthy eating, physical activity, and weight management , much like the NHS's NDPP. One of the key differences is the integration of diabetes risk assessment tools and personalized coaching available through local healthcare providers and community organizations. Diabetes Canada also promotes widespread public awareness campaigns and educational resources to support diabetes prevention across the country. The YMCA Diabetes Prevention Program (DPP) in the US shares a close resemblance with the NHS NDPP. The YMCA DPP is based on the CDC's National Diabetes Prevention Program and involves a one-year, group-based program designed to help participants reduce their risk of type 2 diabetes through lifestyle changes. The program includes 16 weekly sessions followed by monthly maintenance sessions. Participants receive support from a trained lifestyle coach, focusing on weight loss, healthy eating, and physical activity . Like the NDPP, the YMCA DPP has demonstrated success in reducing diabetes risk and improving health outcomes among participants. Summary The NHS's diabetes prevention efforts, particularly through the NDPP, have made significant strides in reducing the risk of type 2 diabetes across the UK . These efforts are comparable to programs in Canada and the US , all emphasizing lifestyle modifications and community support . By learning from and building upon these successful models, the NHS continues to advance its mission of improving public health and preventing diabetes.

Gestational diabetes mellitus (GDM) is a significant health concern that affects a substantial number of pregnancies globally. Known for increasing the risk of type 2 diabetes (T2D) later in life, GDM poses a long-term health risk for women. However, the nuances of how the timing and recurrence of GDM across multiple pregnancies affect future diabetes risk are not as well understood. A recent study conducted by Joseph Mussa and his team, published in May 2024 in JAMA Network Open , offers new insights into this relationship. This retrospective cohort study investigates the incidence of diabetes in women with different patterns of GDM occurrence over two pregnancies, providing crucial data that can enhance our understanding and management of GDM-related diabetes risk. The findings highlight the varying risks associated with GDM occurring in the first pregnancy, the second pregnancy, or both, underscoring the need for tailored prevention strategies based on these patterns. Here's more about this important research Introduction Gestational diabetes mellitus (GDM) is a common pregnancy complication, affecting approximately 14% of pregnancies worldwide. While it is well-established that GDM increases the risk of developing type 2 diabetes (T2D) later in life, this research provides deeper insights into how the timing and recurrence of GDM across multiple pregnancies can influence this risk. Study Overview The study by Mussa et al. is a comprehensive retrospective cohort analysis involving 431,980 women from Quebec, Canada , who had two singleton deliveries between April 1990 and December 2012. The researchers aimed to compare the risks of developing diabetes among women who experienced GDM in their first pregnancy, their second pregnancy, both pregnancies, or neither. Key Findings 1. Incidence Rates and Hazards: Women who experienced GDM in their first pregnancy only had a 4.35-fold increased risk of developing diabetes compared to those with no GDM. The risk was higher for women with GDM in their second pregnancy only, showing a 7.68-fold increase. The highest risk was observed in women who had GDM in both pregnancies, with a staggering 15.8-fold increase in the likelihood of developing diabetes. 2. Comparative Risk: Women with GDM in their second pregnancy had a 76% higher risk of developing diabetes compared to those with GDM only in their first pregnancy. Having GDM in both pregnancies increased the risk by 3.63 times compared to having it only in the first pregnancy. 3. Demographic Insights: The average age at the second delivery was around 30 years. A significant portion of the study population (86.4%) was of European background, with 18.2% being in the highest quintile of material deprivation. Implications for Diabetes Prevention These findings underscore the importance of considering the pattern and timing of GDM occurrences when assessing future diabetes risk. The study suggests that the recurrence of GDM or its occurrence in a second pregnancy might indicate a higher susceptibility to diabetes , warranting more vigilant monitoring and preventive measures. Behavioral and Clinical Interventions For Women with First-Pregnancy GDM: Behavioral changes and clinical interventions following a GDM diagnosis in the first pregnancy might help mitigate the risk of recurrence and subsequent development of T2D. This includes maintaining a healthy weight, engaging in regular physical activity, and adhering to a balanced diet. For Women with Second-Pregnancy GDM : Since these women exhibit a higher risk, tailored strategies focusing on intensive lifestyle modification and possibly pharmacological interventions might be necessary to prevent the transition to T2D. For Women with Recurrent GDM : The extremely high risk in this group calls for comprehensive diabetes prevention programs, including frequent blood glucose monitoring, postpartum screening, and possibly early initiation of diabetes medications. Conclusion The research by Mussa et al. provides critical insights that can help healthcare providers better stratify the risk of diabetes in women with a history of GDM. By acknowledging the differential impact of GDM occurrences across pregnancies, more precise and personalized preventive strategies can be developed. This nuanced approach is crucial in the fight against the rising tide of type 2 diabetes among women of reproductive age. Implications for Clinical Practice The findings of Joseph Mussa's study have significant implications for clinical practice in managing and preventing type 2 diabetes (T2D) among women with a history of gestational diabetes mellitus (GDM). Here’s what this means for healthcare providers: 1. Personalized Risk Assessment Clinicians can use the study's insights to better stratify the risk of developing T2D in women based on their GDM history. Recognizing that the risk varies significantly depending on whether GDM occurred in the first pregnancy, the second pregnancy, or both, allows for a more personalized approach to monitoring and intervention. 2. Enhanced Monitoring Protocols For women who had GDM in their second pregnancy or both pregnancies, the study suggests a much higher risk of developing T2D. This calls for more stringent and frequent monitoring of blood glucose levels postpartum and during subsequent follow-ups. Regular screening for diabetes should be prioritized in these high-risk groups. 3. Targeted Lifestyle Interventions Lifestyle modifications are crucial in diabetes prevention. For women with a history of GDM, especially those with recurrent GDM, healthcare providers should emphasize the importance of maintaining a healthy weight, engaging in regular physical activity, and adopting a balanced diet. Tailored lifestyle intervention programs can be designed to address the specific needs of these high-risk individuals. 4. Preventive Pharmacotherapy In cases where lifestyle modifications alone may not suffice, especially for women with GDM in both pregnancies, early initiation of pharmacological interventions might be considered. Medications such as metformin or other glucose-lowering agents could be part of a comprehensive strategy to prevent the onset of T2D. 5. Patient Education and Support Educating patients about their increased risk and the importance of ongoing management is crucial. Support groups, counseling, and diabetes education programs can empower women with the knowledge and resources they need to effectively manage their health. 6. Collaborative Care Models Implementing a multidisciplinary approach involving obstetricians, endocrinologists, dietitians, and diabetes educators can enhance the management and prevention strategies for women with a history of GDM. This collaborative care model ensures comprehensive support and follow-up, addressing all aspects of the patient's health. 7. Postpartum Follow-Up Given the heightened risk of diabetes post-GDM, postpartum follow-up should include glucose tolerance testing and regular monitoring for early signs of T2D. Establishing a clear postpartum care plan is essential for early detection and intervention. Incorporating the findings of Mussa et al.'s study into clinical practice can significantly improve the management and prevention of T2D in women with a history of GDM. By adopting a personalized, proactive, and multidisciplinary approach, healthcare providers can better address the varying risks associated with different patterns of GDM occurrence, ultimately improving patient outcomes and reducing the burden of diabetes. Read the original article here Mussa, J., Rahme, E., Dahhou, M., Nakhla, M., & Dasgupta, K. (2024). Incident diabetes in women with patterns of gestational diabetes occurrences across 2 pregnancies. *JAMA Network Open*, 7(5), e2410279. doi:10.1001/jamanetworkopen.2024.10279.

Living with diabetes comes with a multitude of challenges, not just from managing the condition itself but also from the social stigma that surrounds it. Misunderstandings and negative stereotypes often lead to damaging judgments and misconceptions, which can significantly impact the mental and physical well-being of those affected. Laura Syron, President and CEO of Diabetes Canada, sheds light on this critical issue in her thought-provoking article. Syron emphasizes the importance of eliminating the stigma attached to diabetes, sharing her personal experiences and insights into how societal perceptions can negatively affect individuals living with the condition. She highlights that diabetes is a complex disease with various types and risk factors, many of which are beyond an individual's control, such as genetics and environment. Yet, people with diabetes frequently face unjust blame and prejudice. In her article, Syron notes the federal government’s decision to cover diabetes medication and devices under its new pharmacare plan as a significant step forward. However, she argues that access to medication alone isn't enough. To truly improve the lives of those living with diabetes, we must address and dismantle the stigma surrounding the condition. Here's an excerpt from Laura Syron’s compelling article: "Those living with diabetes have heard it all: they’re lazy, they lack self-control, or they deliberately do not look after themselves. Not surprisingly then, people with diabetes are left feeling blamed and ashamed — that this life-changing diagnosis is all their fault. I know how that feels. Literally. When I was told that I had diabetes, I felt a wave of immense shame and immediately concluded that I had clearly, somehow, brought it on myself. Not only did I want to keep it secret from others, but I also needed to, so I could 'take care of it myself.'" Syron also addresses the prejudice that people with diabetes face in public and healthcare settings. She describes scenarios where self-care practices, such as checking blood glucose levels or injecting insulin, are mistaken for illicit drug use or intoxication. This misunderstanding can lead to harmful and embarrassing situations, further contributing to the stigma. "People with diabetes can face prejudice in public when their self-care practices, like checking blood glucose levels or injecting insulin for a health emergency, is mistaken for illicit drug use or being intoxicated," she writes. Another critical point Syron makes is the impact of stigma on mental health. The constant judgment and negative perceptions can lead to feelings of low self-esteem, anxiety, and depression, often referred to as "diabetes distress." This psychological toll can be as debilitating as the physical aspects of the disease. "This can all take a damaging psychological toll. Research shows that people with diabetes are at risk of low self-esteem, anxiety and depression. This is often called diabetes distress," Syron explains. To combat these issues, Syron advocates for broad education across society to dispel misconceptions and for targeted education in workplaces and healthcare settings to better support people living with diabetes. She calls for a shift in how we talk about and approach diabetes, moving towards a more understanding and supportive dialogue. "We need broad education across our society to dispel the misconceptions — what I sometimes called the triple threat of diabetes beliefs — misinformation, apathy, and stigma. And we need more targeted education too — in workplaces and healthcare settings to ensure they are more supportive of people living with diabetes." Syron concludes with a powerful message about the need for open dialogue and supportive communities for those living with diabetes: "Perhaps most importantly, we must start having a more open dialogue about diabetes in Canada, so that those of us living with it are more comfortable talking about it. It’s time to eliminate the stigma around diabetes so that the millions of us living with it get to enjoy full and healthy lives." Laura Syron’s article is a vital call to action, urging society to rethink and change how we perceive and talk about diabetes. By eliminating stigma, we can help those living with the condition to lead fuller, healthier lives without the burden of judgment and shame. To read the full article and join the conversation, visit the original post here: Opinion: It's time to eliminate the stigma attached to diabetes. I know how it feels . Also, read more at Diabetes Canada

Prediabetes and Type 2 diabetes mellitus (T2DM) are increasingly prevalent conditions linked to obesity and poor metabolic health. Lifestyle interventions , including exercise, are crucial for managing these conditions, but their effects on appetite regulation have been less explored. Understanding these effects could enhance diabetes management strategies. A systematic review analyzed seven studies focusing on patients with abnormal glycemic control. The studies assessed acute and chronic exercise effects on appetite and related hormones like ghrelin, GLP-1, and PYY. The review aimed to clarify whether exercise influences appetite in these patient groups. Acute exercise , as used in the study, refers to single sessions of physical activity performed within a short timefram e to investigate immediate post-exercise effects on appetite sensations and hormonal responses in patients with prediabetes or type 2 diabetes mellitus. Chronic exercise, as referen ced in the study, denotes longer-term exercise regimens consisting of r epeated sessions over weeks to months, aiming to explore cumulative effects on appetite regulation and metabolic health markers in patients with abnormal glycemic control. Key Findings Acute Exercise Effects Varied Appetite Responses : Acute exercise sessions elicited diverse appetite responses . Some studies reported no significant changes in hunger, satiety, or fullness immediately after exercise, while others observed reduced appetite ratings. Hormonal Responses: Hormonal changes such as decreased ghrelin and increased GLP-1 were inconsistently associated with appetite changes, indicating complex interplay between exercise and hormonal regulation. Chronic Exercise Effects Reduce d Appetite: Chronic exercise interventions generally resulted in either no change or decreased appetite ratings compared to control conditions. Improvements Over Time: Long-term studies showed improvements in satiety and reduced hunger with aerobic endurance or combined resistance and aerobic training. Hormonal Inconsistencies: Despite improved subjective appetite ratings, hormonal responses (e.g., ghrelin, PYY) did not consistently correlate with changes in appetite, suggesting other factors at play. Comparison with Normal Glucose Tolerance Differential Responses: Patients with T2DM exhibited distinct appetite responses compared to individuals with normal glucose tolerance. Notably, postprandial fullness and hunger levels differed between the groups. Hormonal Variations: Hormonal profiles (e.g., ghrelin levels) were consistently altered in patients with T2DM , influencing appetite regulation differently from those with normal glucose tolerance. Clinical Insights Weight Management Support: Exercise-induced reduction in appetite could aid weight management efforts in patients with T2DM, potentially contributing to improved glycemic control and cardiovascular health. Personalized Exercise Plans: Considering the variability in appetite responses, personalized exercise prescriptions tailored to individual needs and responses are crucial. Integration with Other Interventions: Combining exercise with dietary modifications and other lifestyle interventions may enhance overall diabetes management outcomes. What Does This Mean for Patients with T2DM? Enhanced Metabolic Contr ol: Regular exercise , especially when tailored to individual responses, can help regulate appetite, potentially reducing the risk of overeating and weight gain. Long-term Benefits: Sustained exercise programs that promote satiety and reduce hunger may support long-term adherence to healthy lifestyle behaviors, essential for managing T2DM effectively. Hormonal Considerations: Despite hormonal variations, the overall trend towards reduced appetite post-exercise suggests favorable metabolic adaptations that could mitigate complications associated with T2DM. Practitioners should consider individual variability in appetite responses when prescribing exercise for patients with prediabetes or T2DM. Future studies integrating diet and lifestyle factors alongside exercise could provide more comprehensive insights into managing these conditions effectively. Conclusion The systematic review underscores t hat chronic exercise tends to reduce appetite in patients with prediabetes or T2DM , which could support weight management and improve metabolic outcomes. However, individual responses vary widely, highlighting the need for personalized exercise prescriptions and further research into long-term energy balance effects. Future Directions Further research should explore the combined effects of exercise, diet, and other lifestyle factors on appetite regulation and energy balance in patients with prediabetes or T2DM. This holistic approach could optimize diabetes management strategies and improve patient outcomes. By summarizing these findings, healthcare professionals and researchers can better understand how exercise impacts appetite in diabetes management, paving the way for tailored interventions that address both metabolic health and quality of life.

In diabetes research, the role of diet continues to be a pivotal area of exploration. A recent case-control study titled "Nutrient patterns and risk of diabetes mellitus type 2" delves into how specific dietary patterns may influence the likelihood of developing type 2 diabetes (T2DM). Led by Morteza Haramshahi and colleagues, this study published in January 2024 offers intriguing insights into how our dietary choices can impact our health outcomes. Understanding the Study The study enrolled a total of 450 participants, including 225 individuals newly diagnosed with T2DM and 225 healthy controls matched for age, sex, and other demographic factors. Using a validated semi-quantitative food frequency questionnaire (FFQ), researchers meticulously assessed the dietary intake of various nutrients among participants over a specified period. This questionnaire enabled them to gather detailed information on the frequency and portion sizes of foods consumed, allowing for a comprehensive analysis of dietary patterns. To identify distinct nutrient patterns, the researchers employed principal component analysis (PCA), a statistical method that reduces the complexity of data by identifying underlying patterns or factors. Through PCA, three major nutrient patterns were derived from the dietary data: 1. Pattern 1 (NP1): Higher intake of sucrose, animal protein, vitamins E, B1, B12, calcium, phosphorus, zinc, and potassium. No significant association with an increased risk of T2DM compared to controls. 2. Pattern 2 (NP2): Higher intake of fiber, plant protein, vitamins D, B5, copper, and magnesium. No significant association with T2DM risk i n the study cohort. 3. Pattern 3 (NP3): Higher intake of fiber, plant protein, vitamins A, C, B2, and potassium . Individuals adhering closely to NP3 demonstrated a 48% lower risk of developing T2DM compared to those who did not. Key Findings The study's findings provide valuable insights into the relationship between nutrient patterns and the risk of developing T2DM. NP3, characterized by a diet rich in plant-based nutrients such as vitamins A, C, B2, fiber, and potassium , emerged as particularly protective against T2DM. This suggests that diets emphasizing fruits, vegetables, and plant proteins may confer significant health benefits, potentially lowering the risk of developing T2DM . Clinical Insights These findings have several clinical implications: Nutrient Diversity: The study underscores the importance of dietary diversity and the inclusion of a wide range of nutrients in the diet. NP3's association with reduced T2DM risk highlights the potential benefits of a balanced diet rich in fruits, vegetables, and plant-based proteins. Impact of Specific Nutrients: While NP1 and NP2 did not show significant associations with T2DM risk in this study, their nutrient compositions (such as vitamins E, D, B complex, and minerals) provide insights into the complex interplay of different nutrients in metabolic health. Personalized Dietary Recommendations: Healthcare providers can use these insights to tailor dietary recommendations for individuals at risk of T2DM, focusing on nutrient-rich foods and dietary patterns that support overall health and metabolic function. Patient Education Opportunities Understanding these findings presents opportunities for patient education and empowerment: Healthy Eating Tips: Encourage patients to adopt a diet rich in fruits, vegetables, whole grains, and plant proteins. These foods are not only nutrient-dense but also associated with a reduced risk of T2DM. Practical tips include incorporating colorful vegetables into meals, choosing whole grains over refined grains, and opting for lean sources of protein. Balanced Nutrition : Emphasize the importance of achieving a balanced intake of vitamins and minerals. Patients can achieve this by consuming a variety of foods from different food groups. For example, dairy products can provide calcium, while nuts and seeds are rich sources of magnesium and zinc. Individualized Dietary Plans: Discuss personalized dietary plans based on patients' preferences, cultural backgrounds, and health goals. Collaborate with a registered dietitian to create meal plans that align with both nutritional needs and diabetes management goals. Conclusion and Future Directions While this study provides valuable insights, further research is needed to validate these findings and explore the underlying mechanisms at play. Understanding how d ietary patterns influence metabolic health is crucial for developing targeted interventions and policies to combat the rising global burden of T2DM. In summary, the study sheds light on the intricate relationship between diet and diabetes risk , emphasizing the potential benefits of nutrient-rich dietary patterns. By incorporating these insights into everyday food choices, individuals can take proactive steps toward maintaining their health and reducing their risk of developing T2DM. For those interested in delving deeper into the study’s findings, access to the datasets can be requested from the corresponding author. Stay informed and empowered about your health through informed dietary decisions that support overall well-being. This study marks a significant contribution to our understanding of nutrition's role in diabetes prevention, paving the way for future research and health initiatives aimed at promoting metabolic health worldwide.

Dietary habits play a crucial role in our overall health, especially when it comes to conditions like hypertension (HTN). A recent 20-year prospective study , published in the European Journal of Clinical Nutrition in April 2024, sheds light on the profound impact of the Mediterranean diet on reducing the risk of developing HTN over time. Understanding the Study The study, conducted by Michael Georgoulis and colleagues, followed 1415 non-hypertensive adults over two decades to assess the relationship between adherence to the Mediterranean diet and the incidence of hypertension. Participants, who were initially free of hypertension, had their dietary habits evaluated using the MedDietScore—a comprehensive tool that measures adherence to the Mediterranean diet based on a range of dietary components. Key Findings Over the 20-year period, 314 new cases of hypertension were identified among the participants. The study found a significant inverse relationship between adherence to the Mediterranean diet and the incidence of hypertension . Participants with higher baseline MedDietScore, indicating greater adherence to the Mediterranean diet, had substantially lower rates of hypertension. Specifically, those in the highest tertile of MedDietScore at baseline had an 8.7% incidence of hypertension compared to 35.5% in the lowest tertile. A tertile is a statistical term used to divide a set of data into three equal parts. Importantly, sustained adherence to the Mediterranean diet over time showed even more profound benefits . Participants who maintained a high MedDietScore both at baseline and at the 10-year follow-up had a remarkable 47% lower risk of developing hypertension compared to those who consistently scored low on the diet scale. Clinical Insights The findings underscore the protective effects of the Mediterranean diet against hypertension , even after adjusting for various lifestyle factors and clinical parameters such as body mass index, physical activity, smoking, blood pressure levels, and medical history. Each 1-point increase in MedDietScore at baseline was associated with a 7% reduction in the relative risk of hypertension over the 20-year period , highlighting the cumulative benefits of dietary habits on long-term health outcomes. Relevance to Type 2 Diabetes Mellitus (T2DM) Beyond hypertension, the Mediterranean diet has been extensively studied for its impact on other chronic conditions, including T2DM. Similar to hypertension, T2DM shares common risk factors such as obesity, insulin resistance, and inflammation, which dietary patterns can influence. Research suggests that adherence to the Mediterranean diet is associated with improved insulin sensitivity, better glycemic control, and reduced risk of developing T2DM . The emphasis on whole grains, fruits, vegetables, legumes, nuts, and healthy fats aligns with dietary recommendations beneficial for managing blood sugar levels and preventing the onset of T2DM. What Does This Mean for Patients with Hypertension? For individuals concerned about hypertension or those looking to prevent its onset, adopting and maintaining a Mediterranean-style diet could be highly beneficial. The diet, rich in fruits, vegetables, whole grains, fish, nuts, and olive oil, not only supports cardiovascular health but also helps in managing blood pressure levels over time. By e mphasizing wholesome, nutrient-dense foods and minimizing processed foods and saturated fats, individuals can potentially reduce their risk of hypertension and its associated complications. What Does This Mean for Patients with Hypertension and T2DM? For individuals managing both hypertension and T2DM or those at risk for these conditions, adopting a Mediterranean-style diet can offer dual benefits. By promoting cardiovascular health through blood pressure management and supporting glycemic control, this dietary approach provides a holistic strategy for reducing the overall risk of cardiovascular complications. Key Principles of the Mediterranean Diet The Mediterranean diet is celebrated worldwide for its health-promoting benefits and holistic approach to eating. Central to this dietary pattern is a high consumption of plant-based foods . Fruits, vegetables, whole grains, nuts, seeds, and legumes form the foundation of meals, providing essential vitamins, minerals, fiber, and antioxidants crucial for overall health. Healthy fats are another cornerstone of the Mediterranean diet. Olive oil is the primary source of added fat, rich in monounsaturated fats and associated with numerous health benefits, including heart health. Additionally, nuts, seeds, and fatty fish, such as salmon and sardines, contribute to the diet's healthy fat profile, offering omega-3 fatty acids essential for brain and heart health. Moderate consumption of dairy products, particularly yogurt and cheese, is typical in Mediterranean cuisine. Poultry and eggs are also included but in smaller quantities compared to plant-based foods. Fish and seafood , consumed several times a week, provide lean protein and omega-3s, contributing to the diet's protective effects against chronic diseases. Red meat is limited in the Mediterranean diet, with consumption typically reserved for occasional indulgences rather than daily meals. Instead of using excessive salt, Mediterranean dishes are seasoned with herbs, spices, and garlic, not only enhancing flavor but also providing additional health benefits. In addition to its dietary components, the Mediterranean lifestyle emphasizes regular physical activity and social interactions , both of which contribute significantly to overall well-being. This comprehensive approach to health underscores the Mediterranean diet's reputation as a sustainable and enjoyable dietary pattern with numerous health benefits, including reducing the risk of chronic diseases like cardiovascular disease, diabetes, and certain cancers . Conclusion The ATTICA prospective epidemiological study provides compelling evidence that adherence to the Mediterranean diet is associated with a lower incidence of hypertension over a 20-year period. Whether you're aiming to prevent hypertension, T2DM, or manage your overall cardiovascular health, incorporating Mediterranean dietary principles into your daily routine may offer substantial long-term benefits . As we continue to explore the intricate relationship between diet and chronic diseases, studies like this reinforce the pivotal role of dietary patterns in promoting health and preventing disease . By making informed choices about what we eat, we empower ourselves to lead healthier, more vibrant lives.

Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. This condition poses significant health challenges globally, impacting millions of individuals and necessitating comprehensive management strategies to mitigate associated complications. Pathophysiology of Type 2 Diabetes The pathogenesis of T2DM is multifactorial, involving complex interactions between genetic predisposition and environmental factors. Key pathophysiological mechanisms include: 📉 Insulin Resistance: A hallmark of T2DM, insulin resistance primarily affects muscle, liver, and adipose tissues. In skeletal muscle, reduced glucose uptake and utilization lead to hyperglycemia. In the liver, insulin resistance results in inappropriate hepatic glucose production. Adipose tissue dysfunction contributes to altered lipid metabolism and increased free fatty acids, exacerbating insulin resistance. 🔬 Beta-cell Dysfunction: Progressive pancreatic beta-cell dysfunction impairs insulin secretion. Genetic factors, glucotoxicity, lipotoxicity, and inflammatory mediators contribute to beta-cell apoptosis and reduced insulin biosynthesis. 📈 Incretin Effect: The incretin effect, mediated by hormones such as GLP-1 and GIP, is diminished in T2DM. This leads to impaired insulin secretion and inadequate suppression of glucagon, further contributing to hyperglycemia. Video from Diabetes UK Clinical Presentation and Diagnosis T2DM often has an insidious onset, with hyperglycemia developing gradually. Common clinical manifestations include: 🚽 Polyuria and Polydipsia: Resulting from osmotic diuresis due to hyperglycemia. 🍽️ Polyphagia: Increased hunger due to cellular glucose deficiency. 😴 Fatigue: Resulting from metabolic inefficiency and hyperglycemia. 👁️ Blurred Vision: Caused by changes in lens hydration due to fluctuating glucose levels. 🦠 Recurrent Infections: Particularly fungal and bacterial infections due to impaired immune function. Diagnosis is confirmed through blood glucose testing, including fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), and glycated hemoglobin (HbA1c) measurements. Diagnostic criteria are as follows: - FPG ≥ 7.0 mmol/L - 2-hour plasma glucose ≥ 11.1 mmol/L during an OGTT ( 75 g oral glucose) - HbA1c ≥ 6.5% Epidemiology 🌎 In British Columbia, approximately 6.9% of the population is diagnosed with diabetes, with the majority being T2DM cases. This translates to approximately 365,700 individuals living with diabetes. Contributing factors include aging populations, increasing obesity rates, and sedentary lifestyles. Footnote: Diabetes Mellitus (Type 1, 2, and gestational); Statistics from 2022 from statista.com 🌐 Globally, the prevalence of diabetes is staggering. According to the International Diabetes Federation , about 537 million adults were living with diabetes in 2021, projected to rise to 643 million by 2030 and 783 million by 2045. T2DM accounts for approximately 90% of these cases, with significant impacts in low- and middle-income countries. Self-Management Strategies for Patients Effective self-management is crucial for patients with T2DM to achieve glycemic control and prevent complications. Healthcare providers play a vital role in patient education and support. Key strategies recommended by Diabetes Canada include: Video from Diabetes UK 🥗 Dietary Management: Emphasize a balanced diet rich in vegetables, whole grains, lean proteins, and healthy fats. Encourage portion control and regular meal timing to maintain stable blood glucose levels. Limit intake of refined carbohydrates, sugary beverages, and processed foods. 🏃 Physical Activity: Recommend at least 150 minutes of moderate-intensity aerobic activity per week, combined with resistance training exercises. Educate patients on the benefits of regular physical activity in improving insulin sensitivity and cardiovascular health. ⚖️ Weight Management: Advocate for weight loss in overweight or obese patients, highlighting its role in enhancing insulin sensitivity and glycemic control. Provide resources for behavioral weight management programs and support groups. 💊 Medication Adherence: Educate patients on the importance of adhering to prescribed medications, including oral hypoglycemic agents, insulin, and other injectable therapies. Discuss potential side effects and management strategies to improve adherence. 📉 Blood Glucose Monitoring: Instruct patients on proper blood glucose monitoring techniques and the importance of regular monitoring to adjust treatment plans. Utilize continuous glucose monitoring (CGM) systems for patients requiring detailed glucose profiles. ❤️ Management of Comorbidities: Address associated conditions such as hypertension, dyslipidemia, and cardiovascular disease. Implement comprehensive cardiovascular risk reduction strategies, including lifestyle modification and pharmacotherapy. Understanding the pathophysiology, clinical presentation, and self-management strategies for T2DM is essential for healthcare providers to deliver effective patient care. Through patient education and support, providers can empower individuals with T2DM to achieve optimal glycemic control and improve their quality of life. Continuous advancements in diabetes research and treatment options hold promise for better management and outcomes for those living with T2DM. 🔗For more information on what we do to support T2DM prevention - visit T2DNetwork.ca

In a groundbreaking move aimed at revolutionizing patient care, the NHS is set to introduce its first AI-run physiotherapy clinic later this year. This initiative comes amidst soaring demand, lengthy waiting times, and significant staff shortages within the healthcare sector, particularly in physiotherapy. Addressing the Need The new platform, named Flok Health, promises to redefine the patient experience by offering same-day automated video appointments with a digital physiotherapist . This innovation allows patients to receive timely care for musculoskeletal issues such as bac k pain, either through referral from community or primary care settings or through self-referral via an app. Advantages and Challenges The introduction of AI in physiotherapy marks a significant step towar ds reducing waiting lists and easing pressure on healthcare professionals. According to recent NHS data, waiting times for musculoskeletal treatments have surged by 27% in the past year alone. Such delays not only exacerbate patient discomfort but also strain healthcare resources. Flok Health's approach leverages AI to provide personalized care pathways based on real-time patient data, symptoms, and progress. Initial trials have shown promising results, with over 1,000 NHS staff participating in pilot studies reporting experiences comparable to traditional physiotherapy sessions, and in many cases, even better. The Role of AI in Diabetic Care While the focus of Flok Health initially targets musculoskeletal conditions, the implications for diabetic care are profound. Diabetes management often involves regular monitoring, lifestyle adjustments, and timely interventions to prevent complications. AI-driven platforms like Flok could potentially extend their capabilities to include diabetic care , offering real-time monitoring, personalized advice, and immediate support in managing the condition. The Human Touch vs. Technological Innovation Critics caution that AI , while beneficial, cannot fully replace the nuanced judgment and personalized care provided by trained physiotherapists . The Chartered Society of Physiotherapy emphasizes the importance of maintaining high standards of clinical practice and patient safety amid technological advancements. This sentiment underscores the ongoing need for comprehensive research and evaluation to ensure that AI complements rather than supplants human expertise. Looking Ahead As the healthcare landscape evolves, integrating AI into physiotherapy represents a critical stride towards improving accessibility and quality of care. Innovations like Flok Health demonstrate the potential to enhance patient outcomes while addressing systemic challenges within the NHS. While AI-powered physiotherapy clinics signify a bold leap forward in healthcare innovation, their success hinges on striking a delicate balance between technological advancement and human-centered care . As these initiatives expand, ongoing collaboration between technology developers, healthcare providers, and regulatory bodies will be essential in shaping a future where patients receive timely, effective, and compassionate care. The journey towards leveraging AI in healthcare is just beginning , promising a future where technology and humanity work hand in hand to elevate patient care to unprecedented heights.

As awareness about type 2 diabetes continues to grow, recent research and recommendations are highlighting effective strategies for prevention. Here’s a roundup of the latest news and insights from around the world. Weight Loss and Prediabetes Remission A recent study published in Diabetologia has emphasized the significant impact of weight loss on preventing type 2 diabetes, particularly through the remission of prediabetes. The research, conducted by the Deutsches Zentrum fuer Diabetesforschung, suggests that achieving a weight loss-induced remission of prediabetes can provide optimal protection against the progression to type 2 diabetes. This reinforces current medical guidelines recommending at least a 7% reduction in body weight for individuals at risk. Urgent Call for Diabetes Prevention Action Diabetes Australia has issued a report urging immediate and comprehensive action to address the rising incidence of type 2 diabetes. The State of the Nation report highlights the need for public health initiatives focused on lifestyle changes, such as improving diet and increasing physical activity, to curb the growing diabetes epidemic. This call to action underscores the importance of community and governmental support in implementing effective prevention strategies. Promising Advances in Diabetes Prevention and Management Recent insights and advances in the treatment and management of diabetes show promising potential in combating the increasing prevalence of the disease. A comprehensive survey by the University of California - Los Angeles Health Sciences, published in the journal Cell, explores the multifaceted causes of diabetes, including genetic, environmental, and social factors. This understanding is crucial for developing targeted interventions to prevent diabetes and manage its complications. The review highlights significant strides in treatment, such as the FDA-approved teplizumab for type 1 diabetes and new classes of glucose-lowering medications for type 2 diabetes. These advancements not only improve metabolic control but also address related cardiovascular and kidney diseases, offering hope for better management and potential prevention of diabetes in the future. Genes or Environment? A New Model for Understanding Type 2 Diabetes Risk Recent research from Penn State highlights a breakthrough in understanding the risk factors for type 2 diabetes. Traditionally, both genetic predispositions and environmental factors such as air pollution have been recognized as contributors to the development of T2D. However, quantifying their individual impacts has been challenging. A new model, developed by Penn State researchers, offers a clearer picture by distinguishing between these influences. The study reveals that previous estimates overstated the genetic component of T2D risk. When environmental factors were included, the genetic contribution to T2D risk dropped from 37.7% to 28.4%. This suggests that lifestyle and environmental modifications can significantly mitigate T2D risk. Notably, the model also differentiated the health impacts of specific pollutants, identifying nitrogen dioxide (NO2) as a direct cause of T2D, unlike particulate matter (PM2.5), which affects other health conditions. This refined understanding underscores the potential for targeted interventions to reduce T2D risk, offering hope for those with a family history of the disease, and direction for policy development in chronic disease prevention. Irregular Sleep Patterns Increase Risk of Type 2 Diabetes, Study Finds Consistent sleep patterns are crucial for preventing type 2 diabetes, according to recent research from Brigham and Women's Hospital. The study , published in Diabetes Care , found that middle-aged to older adults with irregular sleep durations had a significantly higher risk of developing diabetes. Researchers analyzed sleep patterns over seven nights and followed participants for over seven years, discovering that those with the most irregular sleep patterns had a 34% higher risk of diabetes compared to those with consistent sleep. The study involved over 84,000 participants from the UK Biobank Study, who were initially free of diabetes. Participants wore accelerometers to monitor their sleep and were tracked for approximately 7.5 years. The findings emphasize the importance of regular sleep as a modifiable lifestyle factor in diabetes prevention, offering a simple yet effective strategy to combat the rising prevalence of type 2 diabetes. Delaying Diabetes with Diet and Exercise for Better Long-Term Health A new study highlights the significant long-term health benefits for individuals diagnosed with prediabetes who delay the onset of diabetes through diet and exercise. According to research published in PLOS Medicine by Guangwei Li of the China-Japan Friendship Hospital and colleagues, maintaining a prediabetic status for just four years can substantially reduce the risk of death and diabetes-related complications. The study involved 540 prediabetic participants from the original Da Qing Diabetes Prevention Study, which began in 1986. Participants who delayed diabetes onset for at least four years experienced significantly lower risks of death and cardiovascular events over a 30-year follow-up period compared to those who developed diabetes sooner. These findings emphasize that even a few years of healthy lifestyle changes can yield substantial long-term health benefits. Conclusion The fight against type 2 diabetes is evolving with new research and innovative approaches. Weight loss, dietary changes, and increased physical activity remain cornerstone strategies, while emerging technologies and personalized treatments offer hope for more effective prevention. Public health efforts and individual commitments to healthier lifestyles are crucial in reducing the prevalence of this chronic disease. Take proactive steps towards a healthier future!

The research article titled " Effects of Genetic Risk on Incident Type 2 Diabetes and Glycemia: The T2D-GENE Lifestyle Intervention Trial " explores how a person's genetic risk for Type 2 Diabetes (T2D) influences the effectiveness of lifestyle changes in preventing the disease. This study, conducted in Finland, involved nearly 1,000 men who had prediabetes—a condition where blood sugar levels are higher than normal but not yet high enough to be diagnosed as diabetes. Overview of the Study The researchers wanted to see if a structured lifestyle program, which included healthy eating and regular physical activity, could prevent these men from developing T2D. They also wanted to know if the benefits of this program were different for people with a higher or lower genetic risk of getting T2D. Key Results The findings were quite promising, especially for those with a higher genetic risk for T2D: 1. High Genetic Risk Group: Men who had a higher genetic risk for T2D and participated in the lifestyle program were 70% less likely to develop T2D compared to those who didn’t follow the program. This means that even if someone is genetically more likely to get T2D, making healthy lifestyle changes can significantly reduce their risk. 2. Low Genetic Risk Group: For men with a lower genetic risk, the lifestyle program did not significantly reduce the chances of developing T2D. However, these participants still saw other health benefits from the program, like better blood sugar control and weight loss. 3. Overall Benefits: Regardless of genetic risk, all participants who followed the program had improvements in their overall health. This shows that lifestyle changes like eating better and being more active can help improve health even if they don’t entirely prevent T2D. What This Means for People Trying to Prevent T2D This research has important implications for anyone trying to prevent T2D, especially if you know you have a higher genetic risk: Personalized Prevention: If you have a family history of T2D or genetic factors that put you at higher risk, this study suggests that committing to a healthy lifestyle can make a big difference in whether or not you develop the disease. It’s not just about your genes—your daily choices matter a lot. Lifestyle is Key: For everyone, whether you’re at high risk or not, focusing on healthy eating and regular physical activity is beneficial. These habits can help control blood sugar levels and manage weight, which are critical factors in preventing T2D. Feasibility of Interventions: The lifestyle program used in the study was group-based, making it a supportive and cost-effective approach. This means that such programs could be more accessible to the public, helping more people make healthier choices in a supportive environment. Practical Advice If you’re concerned about T2D, particularly if it runs in your family, here are some steps you can take based on the study’s findings: Get Active: Regular exercise, like walking, cycling, or swimming, can help manage blood sugar levels and keep your weight in check. Eat Healthy: Focus on a balanced diet rich in vegetables, fruits, whole grains, and lean proteins. Try to limit foods high in sugar and unhealthy fats. Join a Support Group: Consider joining a group-based lifestyle program. These programs can offer motivation, support, and practical advice to help you stick to your health goals. Monitor Your Health: Keep an eye on your blood sugar levels, especially if you’re at higher risk. Regular check-ups with your healthcare provider can help catch any changes early. While this study focused exclusively on men, the findings could also be relevant to women, who are equally at risk of developing T2D. Women with a high genetic risk may similarly benefit from lifestyle interventions, such as a balanced diet and regular physical activity. However, the study's limitation in only including male participants means that we don't know for certain if the results are directly applicable to women. Future research should include women to better understand how gender differences might affect the effectiveness of lifestyle interventions in preventing T2D. This research shows that while your genetic risk for T2D is important, it doesn’t determine your future entirely. By adopting healthier lifestyle habits, particularly if you know you’re at higher risk, you can significantly reduce your chances of developing T2D. So, no matter your genetic background, focusing on healthy eating and regular physical activity remains a powerful tool in the fight against T2D.

A recent study highlights a strong bidirectional connection between chronic diabetes complications and mental health disorders. The research, led by Michigan Medicine and the U-M School of Public Health, analyzed insurance claims data from over 500,000 individuals with type 1 or type 2 diabetes and 350,000 without diabetes. Published in Diabetes Care , the findings reveal that individuals with chronic diabetes complications, such as heart attacks, strokes, and nerve damage, are up to three times more likely to have mental health issues like anxiety or depression. Conversely, those with mental health disorders face up to a 2.5 times greater risk of experiencing sustained diabetes complications. The study also found that younger adults with type 1 diabetes are more prone to chronic complications, while those with type 2 diabetes are more likely to experience mental health difficulties. Researchers suggest that direct effects, such as a stroke causing brain damage that leads to depression, and indirect effects, like poor diabetes management due to mental health conditions, contribute to this relationship. Shared risk factors, including obesity and poor glycemic control, also play a role. For healthcare providers, the study highlights the importance of adopting a holistic approach to diabetes management. Routine mental health screenings should be integrated into diabetes care to ensure that patients receive comprehensive support. Collaborating with mental health professionals can further enhance patient care by addressing both diabetes and mental health needs concurrently. Additionally, healthcare providers would benefit from enhanced training in mental health awareness and treatment strategies, equipping them to better recognize and manage mental health issues. Advocating for resources that support mental health screenings and treatments is also crucial to reduce the burden on primary care providers and improve patient care. Addressing mental health issues openly can lead to more effective and integrated care. It is important for patients to understand the connection between their mental health and diabetes, as maintaining good mental health can positively impact diabetes management. Seeking support through mental health resources, whether from healthcare providers, support groups, or mental health professionals, can improve both emotional well-being and disease management. Educating themselves about the relationship between diabetes and mental health will also help patients manage both aspects more effectively and proactively. The findings underscore the need for improved screening protocols in diabetes care. Although some national diabetes centers have begun incorporating depression and distress screenings, there is no universal standard. Researchers call for enhanced resources to support mental health screening and treatment, noting that many diabetes care providers lack specific training in mental health. They advocate for comprehensive care systems that include mental health screenings, accessible insurance coverage, and educational programs for both healthcare providers and patients. The T2D Network is currently working on a related project. The T2D Mental Health Project aims to tackle the complex needs of individuals with both T2D or pre-diabetes and mental health conditions. Initially targeting communities such as Prince George, Grand Forks, Summerland, and Oliver, the initiative focuses on streamlining referrals, coordinating coaching efforts, and aligning with provincial healthcare strategies. Its goal is to reduce emergency visits and reliance on facility-based care while improving patient outcomes and ensuring the program's long-term sustainability.

Type 2 diabetes mellitus (T2D) presents a significant health challenge, particularly among South Asian populations, due to a combination of genetic, lifestyle, and socioeconomic factors. We dove deeper into the existing literature to shed light on effective interventions tailored to this high-risk group, highlighting the importance of culturally sensitive approaches in diabetes care. Key Insights and Clinical Relevance Our umbrella review article was published in the Clinical Journal of Diabetes Care and Control and funded by IHSTS. We analyzed 21 systematic review articles and found success in T2D interventions in South Asian populations, including dietary modifications, physical activity programs, self-management education, and mobile health (mHealth) technologies in improving glycemic control, reducing weight, and increasing patient satisfaction. However, the clinical relevance of these findings is particularly enhanced by their cultural specificity, allowing healthcare providers to tailor interventions more effectively for South Asian individuals. Culturally Tailored Interventions The complex interplay of cultural, genetic, and social factors necessitates nuanced approaches to diabetes management. For example, lifestyle interventions that account for South Asian dietary preferences and cultural practices are crucial. Comprehensive education, support networks, and multidisciplinary teams also play pivotal roles in promoting healthier behaviors and improving outcomes. Furthermore, leveraging community health workers and digital health tools can enhance access to care, aligning with person-centered care principles. Thus, a culturally adapted, holistic approach is indispensable for optimizing diabetes management in South Asian populations. Migration and Acculturation Challenges Migration to Western countries introduces additional complexities. The process of acculturation often leads to significant lifestyle changes, such as adopting Western dietary patterns high in processed foods, which increases the risk of obesity, cardiovascular disease, and diabetes among South Asian migrants. These challenges, compounded by language barriers, lack of health insurance, and unfamiliarity with healthcare systems, necessitate targeted interventions that address the specific needs of migrant populations. Need for Further Research The review also identifies several gaps in the existing research. For instance, there is a need to better understand dietary variations, socioeconomic status, and the differences between urban and rural populations within the South Asian community. These factors significantly influence diabetes risk and management, and addressing them is essential for developing more effective, tailored strategies. Moreover, while genetic factors were briefly explored, there is a clear need for more in-depth research into how genetic diversity among South Asians affects the interpretation of HbA1c as a biomarker and the overall management of diabetes. This genetic complexity suggests that HbA1c might not fully capture the spectrum of glucose control issues, indicating the need for alternative or supplementary monitoring methods. Another critical gap is the sustainability of T2D interventions. Although short-term benefits of lifestyle modifications and dietary changes are well-documented, there is limited evidence on long-term adherence and sustained outcomes. Addressing this gap is crucial for ensuring that interventions lead to enduring health improvements. Family dynamics, religious practices, and traditional beliefs, which significantly influence health behaviors in South Asian communities, were not explored in depth in the review. However, research indicates that family-based approaches and multi-interventional strategies that respect cultural contexts can significantly enhance the effectiveness of diabetes management programs. Our Summary This review offers a comprehensive evaluation of strategies for preventing and managing T2DM within South Asian populations. It highlights the effectiveness of various culturally sensitive interventions, including dietary modifications, physical activity programs, self-management education, mHealth interventions, and community-based lifestyle strategies. These interventions have shown to improve glycemic control, reduce the incidence of T2DM, and enhance overall well-being among South Asians. The findings underscore the necessity of culturally tailored approaches and collaborative efforts to address the unique challenges associated with diabetes care in South Asian communities. Moving forward, there is a need for more research on long-term adherence to interventions and the sustainability of their benefits. Future studies should also explore the impact of family dynamics, religious practices, and traditional beliefs on diabetes management. Developing innovative, evidence-driven community and population-based lifestyle modification programs tailored to South Asian populations is crucial. Additionally, addressing the unique challenges faced by South Asian migrants in Western countries will be vital in improving diabetes care outcomes for this high-risk group.

Mark your calendars for Thursday, September 26th at 12 PM , when renowned author and science communicator Krista Lamb will host a virtual, interactive discussion with two of Canada's top diabetes and mental health researchers. Join Dr. Diana Sherifali (McMaster University) and Dr. Mahavir Agarwal (CAMH) as they explore: - The connection between diabetes and mental health - The role of health coaching in managing type 2 diabetes - How to integrate mental health conversations into diabetes care - Exciting new research on weight gain, mental health medications, and their link to Type 2 diabetes - The relationship between type 2 diabetes and schizophrenia You’ll also have a chance to ask questions during the session. Welcome to Our New Director! We are excited to welcome Margaret English as the new Director of the Type 2 Diabetes Network! With a rich background in healthcare and a passion for innovation, Margaret is ready to lead the charge in transforming diabetes care. Learn more about Margaret and her role on our website . Film Screening: "Low" Save the date! On November 27th, the Type 2 Diabetes Network will co-host a special screening of the short film Low , in partnership with the BC Diabetes Research Network. This 40-minute film sheds light on the challenges of managing diabetes while experiencing homelessness, drawing from the real-life stories of the Calgary Diabetes Advocacy Committee (CDAC). Watch the trailer Where: BC Children’s Hospital Research Institute, 938 West 28th Avenue When : Wednesday, November 27th at 6:30 PM (Reception to follow) Who: Open to anyone 19+ interested in learning more about supporting people with diabetes and homelessness. Join the Type 2 Diabetes Network! The Type 2 Diabetes Network is a collaborative initiative of healthcare professionals, researchers, and organizations committed to improving diabetes outcomes across British Columbia. As a member, you’ll have access to events, educational sessions, and innovative resources—all at no cost. Partner Event: 36th Annual Diabetes Directors Seminar The Endocrine Research Society will host the 36th Diabetes Directors Seminar on Friday, October 18, 2024. This full-day event brings together experts in diabetes care and is perfect for specialists, family physicians, nurses, dietitians, pharmacists, and diabetes educators. Don’t miss out—register now for the latest insights into diabetes therapeutics and clinical care.